{"id":300355,"date":"2025-07-10T19:47:44","date_gmt":"2025-07-10T19:47:44","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/news-events\/data\/gpc-stock-2\/"},"modified":"2025-07-10T19:47:44","modified_gmt":"2025-07-10T19:47:44","slug":"gpc-stock","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/","title":{"rendered":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025"},"content":{"rendered":"
<\/div><\/div>","protected":false},"excerpt":{"rendered":"","protected":false},"author":45,"featured_media":178545,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[21],"tags":[47,39,45],"class_list":["post-300355","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-markets","tag-beginner","tag-platform","tag-stock"],"acf":{"h1":"Pocket Option ph\u00e2n t\u00edch c\u1ed5 phi\u1ebfu GPC","h1_source":{"label":"H1","type":"text","formatted_value":"Pocket Option ph\u00e2n t\u00edch c\u1ed5 phi\u1ebfu GPC"},"description":"Kh\u00e1m ph\u00e1 nh\u1eefng th\u00f4ng tin chi ti\u1ebft v\u1ec1 c\u1ed5 phi\u1ebfu GPC - ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt, tri\u1ec3n v\u1ecdng t\u0103ng tr\u01b0\u1edfng v\u00e0 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 hi\u1ec7u qu\u1ea3 t\u1eeb c\u00e1c chuy\u00ean gia c\u1ee7a Pocket Option. Th\u00f4ng tin c\u1ea7n thi\u1ebft cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 Vi\u1ec7t Nam h\u00f4m nay!","description_source":{"label":"Description","type":"textarea","formatted_value":"Kh\u00e1m ph\u00e1 nh\u1eefng th\u00f4ng tin chi ti\u1ebft v\u1ec1 c\u1ed5 phi\u1ebfu GPC - ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt, tri\u1ec3n v\u1ecdng t\u0103ng tr\u01b0\u1edfng v\u00e0 c\u00e1c chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 hi\u1ec7u qu\u1ea3 t\u1eeb c\u00e1c chuy\u00ean gia c\u1ee7a Pocket Option. Th\u00f4ng tin c\u1ea7n thi\u1ebft cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 Vi\u1ec7t Nam h\u00f4m nay!"},"intro":"B\u00e0i vi\u1ebft n\u00e0y cung c\u1ea5p g\u00f3c nh\u00ecn s\u00e2u s\u1eafc v\u1ec1 c\u1ed5 phi\u1ebfu GPC c\u1ee7a C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm, m\u1ed9t trong nh\u1eefng ch\u1ee9ng kho\u00e1n \u0111\u00e1ng ch\u00fa \u00fd tr\u00ean th\u1ecb tr\u01b0\u1eddng Vi\u1ec7t Nam. Th\u00f4ng qua ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt, \u0111\u00e1nh gi\u00e1 c\u01a1 b\u1ea3n v\u00e0 xem x\u00e9t c\u00e1c y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4, b\u00e0i vi\u1ebft gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh th\u00f4ng minh trong b\u1ed1i c\u1ea3nh th\u1ecb tr\u01b0\u1eddng n\u0103m 2025.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u00e0i vi\u1ebft n\u00e0y cung c\u1ea5p g\u00f3c nh\u00ecn s\u00e2u s\u1eafc v\u1ec1 c\u1ed5 phi\u1ebfu GPC c\u1ee7a C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm, m\u1ed9t trong nh\u1eefng ch\u1ee9ng kho\u00e1n \u0111\u00e1ng ch\u00fa \u00fd tr\u00ean th\u1ecb tr\u01b0\u1eddng Vi\u1ec7t Nam. Th\u00f4ng qua ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt, \u0111\u00e1nh gi\u00e1 c\u01a1 b\u1ea3n v\u00e0 xem x\u00e9t c\u00e1c y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4, b\u00e0i vi\u1ebft gi\u00fap nh\u00e0 \u0111\u1ea7u t\u01b0 \u0111\u01b0a ra quy\u1ebft \u0111\u1ecbnh th\u00f4ng minh trong b\u1ed1i c\u1ea3nh th\u1ecb tr\u01b0\u1eddng n\u0103m 2025."},"body_html":"

T\u1ed5ng quan v\u1ec1 c\u1ed5 phi\u1ebfu GPC v\u00e0 v\u1ecb th\u1ebf c\u1ee7a n\u00f3 trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam<\/h2><\/div>

C\u1ed5 phi\u1ebfu GPC thu\u1ed9c C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm, m\u1ed9t trong nh\u1eefng doanh nghi\u1ec7p d\u01b0\u1ee3c ph\u1ea9m h\u00e0ng \u0111\u1ea7u Vi\u1ec7t Nam \u0111\u01b0\u1ee3c th\u00e0nh l\u1eadp v\u00e0o n\u0103m 1977. V\u1edbi h\u01a1n 40 n\u0103m ph\u00e1t tri\u1ec3n, Imexpharm \u0111\u00e3 x\u00e2y d\u1ef1ng \u0111\u01b0\u1ee3c v\u1ecb th\u1ebf v\u1eefng ch\u1eafc tr\u00ean th\u1ecb tr\u01b0\u1eddng d\u01b0\u1ee3c ph\u1ea9m trong n\u01b0\u1edbc v\u00e0 khu v\u1ef1c. C\u00f4ng ty chuy\u00ean s\u1ea3n xu\u1ea5t v\u00e0 kinh doanh c\u00e1c s\u1ea3n ph\u1ea9m d\u01b0\u1ee3c ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao, \u0111\u1eb7c bi\u1ec7t l\u00e0 kh\u00e1ng sinh v\u00e0 th\u1ef1c ph\u1ea9m ch\u1ee9c n\u0103ng.<\/p><\/div>

Trong b\u1ed1i c\u1ea3nh ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, c\u1ed5 phi\u1ebfu GPC ng\u00e0y c\u00e0ng thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0. Th\u1ecb tr\u01b0\u1eddng d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111\u01b0\u1ee3c d\u1ef1 b\u00e1o s\u1ebd \u0111\u1ea1t t\u1ed1c \u0111\u1ed9 t\u0103ng tr\u01b0\u1edfng k\u00e9p h\u00e0ng n\u0103m (CAGR) kho\u1ea3ng 10-12% trong giai \u0111o\u1ea1n 2023-2028, cao h\u01a1n m\u1ee9c trung b\u00ecnh to\u00e0n c\u1ea7u. \u0110\u00e2y l\u00e0 \u0111\u1ed9ng l\u1ef1c quan tr\u1ecdng cho tri\u1ec3n v\u1ecdng ph\u00e1t tri\u1ec3n c\u1ee7a c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m trong n\u01b0\u1edbc, bao g\u1ed3m Imexpharm.<\/p><\/div>

V\u1ec1 v\u1ecb th\u1ebf c\u1ea1nh tranh, Imexpharm n\u1ed5i b\u1eadt v\u1edbi chi\u1ebfn l\u01b0\u1ee3c ph\u00e1t tri\u1ec3n b\u1ec1n v\u1eefng, t\u1eadp trung v\u00e0o c\u00e1c d\u00f2ng s\u1ea3n ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP v\u00e0 WHO-GMP. \u0110\u00e2y l\u00e0 l\u1ee3i th\u1ebf c\u1ea1nh tranh quan tr\u1ecdng, \u0111\u1eb7c bi\u1ec7t khi ng\u01b0\u1eddi ti\u00eau d\u00f9ng Vi\u1ec7t Nam ng\u00e0y c\u00e0ng quan t\u00e2m \u0111\u1ebfn ch\u1ea5t l\u01b0\u1ee3ng thu\u1ed1c v\u00e0 xu h\u01b0\u1edbng s\u1eed d\u1ee5ng thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc gia t\u0103ng. N\u0103m 2024, Imexpharm \u0111\u00e3 kh\u00e1nh th\u00e0nh nh\u00e0 m\u00e1y s\u1ea3n xu\u1ea5t kh\u00e1ng sinh c\u00f4ng ngh\u1ec7 cao, g\u00f3p ph\u1ea7n n\u00e2ng cao n\u0103ng l\u1ef1c s\u1ea3n xu\u1ea5t v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c s\u1ea3n ph\u1ea9m.<\/p><\/div>

Ch\u1ec9 s\u1ed1<\/th>2022<\/th>2023<\/th>2024<\/th>D\u1ef1 b\u00e1o 2025<\/th><\/tr><\/thead>
Doanh thu (t\u1ef7 VND)<\/td>1,480<\/td>1,650<\/td>1,842<\/td>2,100<\/td><\/tr>
L\u1ee3i nhu\u1eadn r\u00f2ng (t\u1ef7 VND)<\/td>248<\/td>290<\/td>325<\/td>380<\/td><\/tr>
EPS (VND)<\/td>3,750<\/td>4,200<\/td>4,650<\/td>5,400<\/td><\/tr>
ROE (%)<\/td>14.2<\/td>15.3<\/td>16.1<\/td>17.2<\/td><\/tr><\/tbody><\/table><\/div><\/div>

Ph\u00e2n t\u00edch c\u01a1 b\u1ea3n v\u00e0 t\u00e0i ch\u00ednh c\u1ee7a c\u1ed5 phi\u1ebfu GPC<\/h2><\/div>

Ph\u00e2n t\u00edch c\u01a1 b\u1ea3n l\u00e0 b\u01b0\u1edbc quan tr\u1ecdng khi \u0111\u00e1nh gi\u00e1 ti\u1ec1m n\u0103ng c\u1ee7a c\u1ed5 phi\u1ebfu GPC. K\u1ebft qu\u1ea3 kinh doanh c\u1ee7a Imexpharm trong nh\u1eefng n\u0103m g\u1ea7n \u0111\u00e2y cho th\u1ea5y s\u1ef1 t\u0103ng tr\u01b0\u1edfng \u1ed5n \u0111\u1ecbnh. N\u0103m 2024, c\u00f4ng ty \u0111\u1ea1t doanh thu 1,842 t\u1ef7 VND, t\u0103ng 11.6% so v\u1edbi n\u0103m 2023. L\u1ee3i nhu\u1eadn r\u00f2ng \u0111\u1ea1t 325 t\u1ef7 VND, t\u0103ng 12.1% so v\u1edbi n\u0103m tr\u01b0\u1edbc. \u0110\u00e2y l\u00e0 m\u1ee9c t\u0103ng tr\u01b0\u1edfng \u1ea5n t\u01b0\u1ee3ng trong m\u1ed9t th\u1ecb tr\u01b0\u1eddng v\u1eabn c\u00f2n nhi\u1ec1u th\u00e1ch th\u1ee9c.<\/p><\/div>

C\u00e1c ch\u1ec9 s\u1ed1 t\u00e0i ch\u00ednh c\u1ee7a Imexpharm c\u0169ng kh\u00e1 t\u00edch c\u1ef1c. Bi\u00ean l\u1ee3i nhu\u1eadn g\u1ed9p \u0111\u01b0\u1ee3c duy tr\u00ec \u1edf m\u1ee9c 38-40%, cao h\u01a1n m\u1ee9c trung b\u00ecnh ng\u00e0nh. ROE (T\u1ef7 su\u1ea5t l\u1ee3i nhu\u1eadn tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu) \u0111\u1ea1t 16.1% v\u00e0o n\u0103m 2024, t\u0103ng t\u1eeb 15.3% v\u00e0o n\u0103m 2023. T\u1ef7 l\u1ec7 P\/E hi\u1ec7n t\u1ea1i kho\u1ea3ng 12-13 l\u1ea7n, th\u1ea5p h\u01a1n m\u1ee9c trung b\u00ecnh ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m kho\u1ea3ng 15-16 l\u1ea7n, cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a c\u1ed5 phi\u1ebfu.<\/p><\/div>

Ph\u00e2n t\u00edch c\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1<\/h3><\/div>
Ch\u1ec9 s\u1ed1<\/th>GPC<\/th>Trung b\u00ecnh ng\u00e0nh<\/th>\u0110\u00e1nh gi\u00e1<\/th><\/tr><\/thead>
P\/E<\/td>12.5<\/td>15.8<\/td>H\u1ea5p d\u1eabn<\/td><\/tr>
P\/B<\/td>1.98<\/td>2.25<\/td>H\u1ee3p l\u00fd<\/td><\/tr>
EV\/EBITDA<\/td>8.2<\/td>9.5<\/td>H\u1ea5p d\u1eabn<\/td><\/tr>
L\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c (%)<\/td>3.5<\/td>2.8<\/td>T\u1ed1t<\/td><\/tr><\/tbody><\/table><\/div><\/div>

V\u1ec1 t\u00ecnh h\u00ecnh t\u00e0i ch\u00ednh, Imexpharm c\u00f3 c\u1ea5u tr\u00fac v\u1ed1n l\u00e0nh m\u1ea1nh v\u1edbi t\u1ef7 l\u1ec7 n\u1ee3 tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu th\u1ea5p (kho\u1ea3ng 0.3 l\u1ea7n). C\u00f4ng ty c\u00f3 l\u01b0\u1ee3ng ti\u1ec1n m\u1eb7t d\u1ed3i d\u00e0o, chi\u1ebfm kho\u1ea3ng 15% t\u1ed5ng t\u00e0i s\u1ea3n, cho ph\u00e9p doanh nghi\u1ec7p c\u00f3 \u0111\u1ee7 ngu\u1ed3n l\u1ef1c \u0111\u1ec3 t\u00e0i tr\u1ee3 cho c\u00e1c d\u1ef1 \u00e1n m\u1edf r\u1ed9ng v\u00e0 nghi\u00ean c\u1ee9u ph\u00e1t tri\u1ec3n s\u1ea3n ph\u1ea9m m\u1edbi. \u0110\u1eb7c bi\u1ec7t, trong b\u1ed1i c\u1ea3nh l\u00e3i su\u1ea5t gi\u1ea3m hi\u1ec7n nay, n\u1ee3 th\u1ea5p c\u1ee7a Imexpharm l\u00e0 m\u1ed9t l\u1ee3i th\u1ebf \u0111\u00e1ng k\u1ec3.<\/p><\/div>

M\u1ed9t \u0111i\u1ec3m \u0111\u00e1ng ch\u00fa \u00fd kh\u00e1c l\u00e0 ch\u00ednh s\u00e1ch c\u1ed5 t\u1ee9c c\u1ee7a c\u00f4ng ty. Imexpharm duy tr\u00ec vi\u1ec7c chi tr\u1ea3 c\u1ed5 t\u1ee9c \u0111\u1ec1u \u0111\u1eb7n kho\u1ea3ng 15-20% b\u1eb1ng ti\u1ec1n m\u1eb7t v\u00e0 c\u1ed5 phi\u1ebfu, th\u1ec3 hi\u1ec7n cam k\u1ebft chia s\u1ebb l\u1ee3i nhu\u1eadn v\u1edbi c\u1ed5 \u0111\u00f4ng. \u1ede m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i, l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a c\u1ed5 phi\u1ebfu GPC kho\u1ea3ng 3.5%, cao h\u01a1n l\u00e3i su\u1ea5t ti\u1ec1n g\u1eedi ng\u00e2n h\u00e0ng v\u00e0 m\u1ee9c trung b\u00ecnh ng\u00e0nh.<\/p><\/div>

Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt v\u00e0 xu h\u01b0\u1edbng giao d\u1ecbch c\u1ee7a c\u1ed5 phi\u1ebfu GPC<\/h2><\/div>

Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt cung c\u1ea5p c\u00e1i nh\u00ecn s\u00e2u s\u1eafc v\u1ec1 xu h\u01b0\u1edbng gi\u00e1 v\u00e0 \u0111i\u1ec3m v\u00e0o\/ra l\u00fd t\u01b0\u1edfng cho nh\u00e0 \u0111\u1ea7u t\u01b0. Theo bi\u1ec3u \u0111\u1ed3 k\u1ef9 thu\u1eadt, c\u1ed5 phi\u1ebfu GPC \u0111\u00e3 tr\u1ea3i qua giai \u0111o\u1ea1n t\u00edch l\u0169y trong s\u00e1u th\u00e1ng \u0111\u1ea7u n\u0103m 2024 v\u00e0 b\u1eaft \u0111\u1ea7u xu h\u01b0\u1edbng t\u0103ng t\u1eeb Q3\/2024. Hi\u1ec7n t\u1ea1i, c\u1ed5 phi\u1ebfu \u0111ang giao d\u1ecbch tr\u00ean MA50 (\u0111\u01b0\u1eddng trung b\u00ecnh \u0111\u1ed9ng 50 ng\u00e0y) v\u00e0 MA200 (\u0111\u01b0\u1eddng trung b\u00ecnh \u0111\u1ed9ng 200 ng\u00e0y), x\u00e1c nh\u1eadn xu h\u01b0\u1edbng t\u0103ng trung v\u00e0 d\u00e0i h\u1ea1n.<\/p><\/div>

C\u00e1c ch\u1ec9 b\u00e1o k\u1ef9 thu\u1eadt nh\u01b0 RSI (Ch\u1ec9 s\u1ed1 s\u1ee9c m\u1ea1nh t\u01b0\u01a1ng \u0111\u1ed1i) \u1edf m\u1ee9c 65, cho th\u1ea5y c\u1ed5 phi\u1ebfu ch\u01b0a v\u00e0o v\u00f9ng qu\u00e1 mua. MACD c\u0169ng n\u1eb1m tr\u00ean \u0111\u01b0\u1eddng t\u00edn hi\u1ec7u v\u1edbi \u0111\u1ed9ng l\u01b0\u1ee3ng t\u00edch c\u1ef1c. Kh\u1ed1i l\u01b0\u1ee3ng giao d\u1ecbch trung b\u00ecnh trong 20 phi\u00ean g\u1ea7n nh\u1ea5t t\u0103ng 30% so v\u1edbi 20 phi\u00ean tr\u01b0\u1edbc \u0111\u00f3, ph\u1ea3n \u00e1nh s\u1ef1 quan t\u00e2m ng\u00e0y c\u00e0ng t\u0103ng c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0.<\/p><\/div>

Ch\u1ec9 b\u00e1o k\u1ef9 thu\u1eadt<\/th>Gi\u00e1 tr\u1ecb hi\u1ec7n t\u1ea1i<\/th>T\u00edn hi\u1ec7u<\/th><\/tr><\/thead>
RSI (14)<\/td>65<\/td>T\u00edch c\u1ef1c<\/td><\/tr>
MACD (12,26,9)<\/td>+2.15<\/td>Mua<\/td><\/tr>
Bollinger Bands<\/td>Giao d\u1ecbch g\u1ea7n d\u1ea3i tr\u00ean<\/td>T\u00edch c\u1ef1c<\/td><\/tr>
Stochastic<\/td>82<\/td>G\u1ea7n v\u00f9ng qu\u00e1 mua<\/td><\/tr><\/tbody><\/table><\/div><\/div>

V\u1ec1 m\u1ee9c kh\u00e1ng c\u1ef1 v\u00e0 h\u1ed7 tr\u1ee3, c\u1ed5 phi\u1ebfu GPC hi\u1ec7n c\u00f3 kh\u00e1ng c\u1ef1 m\u1ea1nh \u1edf m\u1ee9c gi\u00e1 65,000 VND, t\u01b0\u01a1ng \u1ee9ng v\u1edbi \u0111\u1ec9nh cao nh\u1ea5t trong l\u1ecbch s\u1eed giao d\u1ecbch. C\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 quan tr\u1ecdng l\u00e0 58,000 VND (MA50) v\u00e0 52,000 VND (MA200). Chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch ph\u00f9 h\u1ee3p l\u00e0 t\u00edch l\u0169y mua t\u1ea1i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 n\u00e0y v\u00e0 c\u00e2n nh\u1eafc ch\u1ed1t l\u1eddi m\u1ed9t ph\u1ea7n khi ti\u1ebfp c\u1eadn c\u00e1c v\u00f9ng kh\u00e1ng c\u1ef1.<\/p><\/div>

Theo c\u00e1c nh\u00e0 ph\u00e2n t\u00edch t\u1ea1i Pocket Option, v\u1edbi \u0111\u1ed9ng l\u1ef1c hi\u1ec7n t\u1ea1i, c\u1ed5 phi\u1ebfu GPC c\u00f3 kh\u1ea3 n\u0103ng v\u01b0\u1ee3t qua m\u1ee9c kh\u00e1ng c\u1ef1 65,000 VND trong Q2\/2025, \u0111\u1eb7c bi\u1ec7t n\u1ebfu k\u1ebft qu\u1ea3 kinh doanh Q1\/2025 ti\u1ebfp t\u1ee5c kh\u1ea3 quan. Tuy nhi\u00ean, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u1ea7n ch\u00fa \u00fd \u0111\u1ebfn c\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro nh\u01b0 bi\u1ebfn \u0111\u1ed9ng chung c\u1ee7a th\u1ecb tr\u01b0\u1eddng v\u00e0 \u0111i\u1ec1u ki\u1ec7n kinh t\u1ebf v\u0129 m\u00f4 c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn xu h\u01b0\u1edbng gi\u00e1.<\/p><\/div>

M\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt \u0111\u00e1ng ch\u00fa \u00fd<\/h3><\/div>

G\u1ea7n \u0111\u00e2y, c\u1ed5 phi\u1ebfu GPC \u0111\u00e3 h\u00ecnh th\u00e0nh m\u00f4 h\u00ecnh \"Cup and Handle\" - m\u1ed9t m\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt b\u00e1o hi\u1ec7u ti\u1ec1m n\u0103ng b\u1ee9t ph\u00e1 gi\u00e1 m\u1ea1nh. \"Cup\" \u0111\u01b0\u1ee3c h\u00ecnh th\u00e0nh trong 4 th\u00e1ng \u0111\u1ea7u n\u0103m 2024, ti\u1ebfp theo l\u00e0 giai \u0111o\u1ea1n \"handle\" k\u00e9o d\u00e0i kho\u1ea3ng 6-8 tu\u1ea7n. Theo l\u00fd thuy\u1ebft ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt, m\u1ee5c ti\u00eau gi\u00e1 sau khi ho\u00e0n th\u00e0nh m\u00f4 h\u00ecnh n\u00e0y c\u00f3 th\u1ec3 cao h\u01a1n 15-20% so v\u1edbi m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i.<\/p><\/div>

  • M\u00f4 h\u00ecnh \"Cup and Handle\" th\u01b0\u1eddng b\u00e1o hi\u1ec7u xu h\u01b0\u1edbng t\u0103ng m\u1ea1nh<\/li>
  • Kh\u1ed1i l\u01b0\u1ee3ng giao d\u1ecbch t\u0103ng khi c\u1ed5 phi\u1ebfu v\u01b0\u1ee3t qua v\u00e0nh c\u1ed1c l\u00e0 t\u00edn hi\u1ec7u x\u00e1c nh\u1eadn quan tr\u1ecdng<\/li>
  • M\u1ee5c ti\u00eau gi\u00e1 c\u00f3 th\u1ec3 \u0111\u1ea1t 72,000-75,000 VND n\u1ebfu m\u00f4 h\u00ecnh n\u00e0y ho\u00e0n th\u00e0nh<\/li><\/ul><\/div>

    C\u00e1c y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn tri\u1ec3n v\u1ecdng c\u1ed5 phi\u1ebfu GPC<\/h2><\/div>

    M\u00f4i tr\u01b0\u1eddng kinh t\u1ebf v\u0129 m\u00f4 \u0111\u00f3ng vai tr\u00f2 quan tr\u1ecdng trong vi\u1ec7c \u0111\u1ecbnh h\u00ecnh tri\u1ec3n v\u1ecdng c\u1ee7a c\u1ed5 phi\u1ebfu GPC. N\u0103m 2025, kinh t\u1ebf Vi\u1ec7t Nam \u0111\u01b0\u1ee3c d\u1ef1 b\u00e1o t\u0103ng tr\u01b0\u1edfng kho\u1ea3ng 6.5-7%, v\u1edbi l\u1ea1m ph\u00e1t \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t \u1edf m\u1ee9c 3.5-4%. L\u00e3i su\u1ea5t ti\u1ebfp t\u1ee5c th\u1ea5p s\u1ebd t\u1ea1o \u0111i\u1ec1u ki\u1ec7n thu\u1eadn l\u1ee3i cho doanh nghi\u1ec7p m\u1edf r\u1ed9ng \u0111\u1ea7u t\u01b0.<\/p><\/div>

    Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111ang h\u01b0\u1edfng l\u1ee3i t\u1eeb nhi\u1ec1u xu h\u01b0\u1edbng t\u00edch c\u1ef1c. Th\u1ee9 nh\u1ea5t, d\u00e2n s\u1ed1 gi\u00e0 h\u00f3a v\u00e0 t\u1ea7ng l\u1edbp trung l\u01b0u ng\u00e0y c\u00e0ng t\u0103ng \u0111ang th\u00fac \u0111\u1ea9y nhu c\u1ea7u ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe v\u00e0 d\u01b0\u1ee3c ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao. Th\u1ee9 hai, ch\u00ednh s\u00e1ch b\u1ea3o hi\u1ec3m y t\u1ebf to\u00e0n d\u00e2n c\u1ee7a Ch\u00ednh ph\u1ee7 gi\u00fap m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng v\u00e0 t\u1ea1o nhu c\u1ea7u \u1ed5n \u0111\u1ecbnh cho thu\u1ed1c n\u1ed9i \u0111\u1ecba. Th\u1ee9 ba, xu h\u01b0\u1edbng \"Make in Vietnam\" v\u00e0 c\u00e1c ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc trong \u0111\u1ea5u th\u1ea7u t\u1ea1i c\u00e1c c\u01a1 s\u1edf y t\u1ebf c\u00f4ng l\u1eadp t\u1ea1o l\u1ee3i th\u1ebf cho c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m trong n\u01b0\u1edbc nh\u01b0 Imexpharm.<\/p><\/div>

    Y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4<\/th>T\u00e1c \u0111\u1ed9ng \u0111\u1ebfn GPC<\/th><\/tr><\/thead>
    T\u0103ng tr\u01b0\u1edfng GDP 6.5-7%<\/td>T\u00edch c\u1ef1c<\/td><\/tr>
    L\u1ea1m ph\u00e1t \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t \u1edf m\u1ee9c 3.5-4%<\/td>T\u00edch c\u1ef1c<\/td><\/tr>
    L\u00e3i su\u1ea5t th\u1ea5p<\/td>T\u00edch c\u1ef1c<\/td><\/tr>
    Ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c n\u1ed9i \u0111\u1ecba<\/td>R\u1ea5t t\u00edch c\u1ef1c<\/td><\/tr>
    D\u00e2n s\u1ed1 gi\u00e0 h\u00f3a<\/td>T\u00edch c\u1ef1c d\u00e0i h\u1ea1n<\/td><\/tr><\/tbody><\/table><\/div><\/div>

    \u0110\u00e1ng ch\u00fa \u00fd, EVFTA (Hi\u1ec7p \u0111\u1ecbnh Th\u01b0\u01a1ng m\u1ea1i T\u1ef1 do EU-Vi\u1ec7t Nam), c\u00f3 hi\u1ec7u l\u1ef1c ho\u00e0n to\u00e0n t\u1eeb n\u0103m 2024, m\u1edf ra c\u01a1 h\u1ed9i xu\u1ea5t kh\u1ea9u d\u01b0\u1ee3c ph\u1ea9m sang th\u1ecb tr\u01b0\u1eddng EU cho c\u00e1c c\u00f4ng ty \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP nh\u01b0 Imexpharm. \u0110\u00e2y l\u00e0 c\u01a1 h\u1ed9i l\u1edbn \u0111\u1ec3 c\u00f4ng ty m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng v\u00e0 t\u0103ng doanh thu xu\u1ea5t kh\u1ea9u trong nh\u1eefng n\u0103m t\u1edbi.<\/p><\/div>

    Tuy nhi\u00ean, c\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro c\u0169ng c\u1ea7n \u0111\u01b0\u1ee3c l\u01b0u \u00fd. C\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m n\u01b0\u1edbc ngo\u00e0i v\u1edbi ti\u1ec1m l\u1ef1c t\u00e0i ch\u00ednh m\u1ea1nh v\u00e0 c\u00f4ng ngh\u1ec7 ti\u00ean ti\u1ebfn ng\u00e0y c\u00e0ng gay g\u1eaft. Chi ph\u00ed \u0111\u1ea7u v\u00e0o t\u0103ng do bi\u1ebfn \u0111\u1ed9ng t\u1ef7 gi\u00e1 v\u00e0 gi\u00e1 nguy\u00ean li\u1ec7u d\u01b0\u1ee3c ph\u1ea9m tr\u00ean th\u1ecb tr\u01b0\u1eddng th\u1ebf gi\u1edbi c\u0169ng l\u00e0 th\u00e1ch th\u1ee9c l\u1edbn. Ngo\u00e0i ra, thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch qu\u1ea3n l\u00fd d\u01b0\u1ee3c ph\u1ea9m v\u00e0 \u0111\u1ea5u th\u1ea7u thu\u1ed1c c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn k\u1ebft qu\u1ea3 kinh doanh c\u1ee7a c\u00f4ng ty.<\/p><\/div>

    Chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 ph\u00f9 h\u1ee3p cho c\u1ed5 phi\u1ebfu GPC trong n\u0103m 2025<\/h2><\/div>

    D\u1ef1a tr\u00ean ph\u00e2n t\u00edch c\u01a1 b\u1ea3n, ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt v\u00e0 c\u00e1c y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4, c\u00e1c chuy\u00ean gia t\u1ea1i Pocket Option \u0111\u1ec1 xu\u1ea5t m\u1ed9t s\u1ed1 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 ph\u00f9 h\u1ee3p cho c\u1ed5 phi\u1ebfu GPC trong n\u0103m 2025:<\/p><\/div>

    Ph\u00e2n b\u1ed5 danh m\u1ee5c theo th\u1eddi gian n\u1eafm gi\u1eef<\/h3><\/div>
    • \u0110\u1ea7u t\u01b0 d\u00e0i h\u1ea1n (tr\u00ean 12 th\u00e1ng): Ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm l\u1ee3i nhu\u1eadn t\u1eeb t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng c\u1ee7a c\u00f4ng ty v\u00e0 c\u1ed5 t\u1ee9c \u0111\u1ec1u \u0111\u1eb7n. C\u00f3 th\u1ec3 ph\u00e2n b\u1ed5 5-10% danh m\u1ee5c cho GPC.<\/li>
    • \u0110\u1ea7u t\u01b0 trung h\u1ea1n (3-6 th\u00e1ng): T\u1eadn d\u1ee5ng xu h\u01b0\u1edbng t\u0103ng hi\u1ec7n t\u1ea1i c\u1ee7a c\u1ed5 phi\u1ebfu v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng m\u1ea1nh trong n\u0103m 2025.<\/li>
    • Giao d\u1ecbch ng\u1eafn h\u1ea1n: Ch\u1ec9 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 kinh nghi\u1ec7m, d\u1ef1a tr\u00ean c\u00e1c t\u00edn hi\u1ec7u k\u1ef9 thu\u1eadt v\u00e0 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 ng\u1eafn h\u1ea1n.<\/li><\/ul><\/div>
      Lo\u1ea1i nh\u00e0 \u0111\u1ea7u t\u01b0<\/th>Chi\u1ebfn l\u01b0\u1ee3c<\/th>Th\u1eddi \u0111i\u1ec3m mua<\/th>M\u1ee5c ti\u00eau gi\u00e1<\/th>C\u1eaft l\u1ed7<\/th><\/tr><\/thead>
      D\u00e0i h\u1ea1n<\/td>T\u00edch l\u0169y d\u1ea7n<\/td>Gi\u00e1 quanh MA200<\/td>75,000-80,000<\/td>D\u01b0\u1edbi MA200 trong th\u1eddi gian d\u00e0i<\/td><\/tr>
      Trung h\u1ea1n<\/td>Mua khi b\u1ee9t ph\u00e1<\/td>V\u01b0\u1ee3t 65,000 v\u1edbi kh\u1ed1i l\u01b0\u1ee3ng<\/td>72,000-75,000<\/td>D\u01b0\u1edbi 58,000<\/td><\/tr>
      Ng\u1eafn h\u1ea1n<\/td>Giao d\u1ecbch theo s\u00f3ng<\/td>Ki\u1ec3m tra h\u1ed7 tr\u1ee3 th\u00e0nh c\u00f4ng<\/td>65,000-68,000<\/td>V\u01b0\u1ee3t d\u01b0\u1edbi h\u1ed7 tr\u1ee3 g\u1ea7n nh\u1ea5t<\/td><\/tr><\/tbody><\/table><\/div><\/div>

      \u0110\u1ed1i v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n, chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 l\u00e0 ph\u00f9 h\u1ee3p, t\u1ee9c l\u00e0 mua c\u1ed5 phi\u1ebfu GPC \u0111\u1ec1u \u0111\u1eb7n h\u00e0ng th\u00e1ng ho\u1eb7c h\u00e0ng qu\u00fd, b\u1ea5t k\u1ec3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 ng\u1eafn h\u1ea1n. Chi\u1ebfn l\u01b0\u1ee3c n\u00e0y gi\u00fap gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi th\u1ecb tr\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng v\u00e0 t\u1ed1i \u01b0u h\u00f3a gi\u00e1 v\u1ed1n trung b\u00ecnh trong d\u00e0i h\u1ea1n.<\/p><\/div>

      \u0110\u1ed1i v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 trung h\u1ea1n, c\u1ea7n ch\u00fa \u00fd \u0111\u1ebfn c\u01a1 h\u1ed9i khi c\u1ed5 phi\u1ebfu GPC \u0111i\u1ec1u ch\u1ec9nh v\u1ec1 c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 quan tr\u1ecdng nh\u01b0 MA50 ho\u1eb7c MA200. \u0110\u00e2y th\u01b0\u1eddng l\u00e0 th\u1eddi \u0111i\u1ec3m thu\u1eadn l\u1ee3i \u0111\u1ec3 tham gia ho\u1eb7c t\u0103ng t\u1ef7 tr\u1ecdng. M\u1ee5c ti\u00eau gi\u00e1 trong 6-12 th\u00e1ng t\u1edbi c\u00f3 th\u1ec3 \u0111\u1ea1t 72,000-75,000 VND, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 15-20% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i.<\/p><\/div>

      \u0110\u1ed1i v\u1edbi nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n, k\u1ebft h\u1ee3p ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt v\u1edbi vi\u1ec7c theo d\u00f5i d\u00f2ng ti\u1ec1n th\u1ecb tr\u01b0\u1eddng v\u00e0 th\u00f4ng tin c\u00f4ng ty l\u00e0 chi\u1ebfn l\u01b0\u1ee3c hi\u1ec7u qu\u1ea3. C\u00e1c t\u00edn hi\u1ec7u t\u1eeb ch\u1ec9 b\u00e1o RSI, MACD v\u00e0 m\u00f4 h\u00ecnh n\u1ebfn c\u00f3 th\u1ec3 cung c\u1ea5p \u0111i\u1ec3m v\u00e0o\/ra ch\u00ednh x\u00e1c. Chi\u1ebfn l\u01b0\u1ee3c \"mua t\u1ea1i h\u1ed7 tr\u1ee3, b\u00e1n t\u1ea1i kh\u00e1ng c\u1ef1\" l\u00e0 ph\u00f9 h\u1ee3p trong b\u1ed1i c\u1ea3nh c\u1ed5 phi\u1ebfu \u0111ang trong xu h\u01b0\u1edbng t\u0103ng.<\/p><\/div>

      C\u00e1c chuy\u00ean gia t\u1ea1i Pocket Option khuy\u1ebfn ngh\u1ecb nh\u00e0 \u0111\u1ea7u t\u01b0 \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c \u0111\u1ea7u t\u01b0, kh\u00f4ng t\u1eadp trung qu\u00e1 nhi\u1ec1u v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu duy nh\u1ea5t. GPC n\u00ean chi\u1ebfm t\u1ef7 tr\u1ecdng h\u1ee3p l\u00fd trong danh m\u1ee5c t\u00f9y thu\u1ed9c v\u00e0o kh\u1ea9u v\u1ecb r\u1ee7i ro v\u00e0 m\u1ee5c ti\u00eau \u0111\u1ea7u t\u01b0 c\u1ee7a m\u1ed7i ng\u01b0\u1eddi.<\/p><\/div>

      R\u1ee7i ro v\u00e0 qu\u1ea3n l\u00fd r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o GPC<\/h2><\/div>

      M\u1eb7c d\u00f9 tri\u1ec3n v\u1ecdng c\u1ee7a c\u1ed5 phi\u1ebfu GPC kh\u00e1 t\u00edch c\u1ef1c, nh\u00e0 \u0111\u1ea7u t\u01b0 v\u1eabn c\u1ea7n nh\u1eadn di\u1ec7n v\u00e0 qu\u1ea3n l\u00fd c\u00e1c r\u1ee7i ro sau:<\/p><\/div>

      • R\u1ee7i ro ng\u00e0nh: C\u1ea1nh tranh gay g\u1eaft trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m, thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch qu\u1ea3n l\u00fd gi\u00e1 thu\u1ed1c<\/li>
      • R\u1ee7i ro kinh t\u1ebf v\u0129 m\u00f4: Bi\u1ebfn \u0111\u1ed9ng t\u1ef7 gi\u00e1, l\u1ea1m ph\u00e1t cao \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn chi ph\u00ed \u0111\u1ea7u v\u00e0o<\/li>
      • R\u1ee7i ro kinh doanh: K\u1ebft qu\u1ea3 kinh doanh kh\u00f4ng \u0111\u1ea1t k\u1ef3 v\u1ecdng, d\u1ef1 \u00e1n \u0111\u1ea7u t\u01b0 m\u1edbi b\u1ecb tr\u00ec ho\u00e3n<\/li>
      • R\u1ee7i ro th\u1ecb tr\u01b0\u1eddng: Bi\u1ebfn \u0111\u1ed9ng chung c\u1ee7a th\u1ecb tr\u01b0\u1eddng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u00e2m l\u00fd nh\u00e0 \u0111\u1ea7u t\u01b0<\/li><\/ul><\/div>

        \u0110\u1ec3 qu\u1ea3n l\u00fd r\u1ee7i ro hi\u1ec7u qu\u1ea3, nh\u00e0 \u0111\u1ea7u t\u01b0 n\u00ean \u00e1p d\u1ee5ng c\u00e1c nguy\u00ean t\u1eafc sau:<\/p><\/div>

        Nguy\u00ean t\u1eafc<\/th>Th\u1ef1c hi\u1ec7n<\/th><\/tr><\/thead>
        \u0110a d\u1ea1ng h\u00f3a danh m\u1ee5c<\/td>Kh\u00f4ng \u0111\u1ea7u t\u01b0 qu\u00e1 10% danh m\u1ee5c v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu<\/td><\/tr>
        \u0110\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7<\/td>C\u1eaft l\u1ed7 khi gi\u00e1 gi\u1ea3m 7-10% so v\u1edbi gi\u00e1 mua<\/td><\/tr>
        Ph\u00e2n b\u1ed5 v\u1ed1n theo giai \u0111o\u1ea1n<\/td>Chia nh\u1ecf l\u1ec7nh mua th\u00e0nh nhi\u1ec1u \u0111\u1ee3t<\/td><\/tr>
        C\u1eadp nh\u1eadt th\u00f4ng tin<\/td>Theo d\u00f5i s\u00e1t sao k\u1ebft qu\u1ea3 kinh doanh v\u00e0 th\u00f4ng tin c\u00f4ng ty<\/td><\/tr><\/tbody><\/table><\/div><\/div>

        Ngo\u00e0i ra, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng c\u00e1c c\u00f4ng c\u1ee5 qu\u1ea3n l\u00fd r\u1ee7i ro tr\u00ean n\u1ec1n t\u1ea3ng Pocket Option nh\u01b0 Stop Loss, Take Profit v\u00e0 c\u00e1c t\u00ednh n\u0103ng ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt \u0111\u1ec3 theo d\u00f5i v\u00e0 \u0111i\u1ec1u ch\u1ec9nh danh m\u1ee5c \u0111\u1ea7u t\u01b0 k\u1ecbp th\u1eddi.<\/p><\/div>

        K\u1ebft lu\u1eadn v\u1ec1 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu GPC trong n\u0103m 2025<\/h2><\/div>

        T\u00f3m l\u1ea1i, c\u1ed5 phi\u1ebfu GPC c\u1ee7a C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm cho th\u1ea5y ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 t\u00edch c\u1ef1c trong n\u0103m 2025. V\u1edbi n\u1ec1n t\u1ea3ng c\u01a1 b\u1ea3n v\u1eefng ch\u1eafc, t\u0103ng tr\u01b0\u1edfng kinh doanh \u1ed5n \u0111\u1ecbnh v\u00e0 \u0111\u1ecbnh gi\u00e1 h\u1ee3p l\u00fd, GPC l\u00e0 l\u1ef1a ch\u1ecdn \u0111\u00e1ng c\u00e2n nh\u1eafc cho c\u1ea3 nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n v\u00e0 trung h\u1ea1n.<\/p><\/div>

        C\u00e1c y\u1ebfu t\u1ed1 h\u1ed7 tr\u1ee3 t\u0103ng tr\u01b0\u1edfng bao g\u1ed3m: (1) Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111ang trong chu k\u1ef3 t\u0103ng tr\u01b0\u1edfng m\u1ea1nh; (2) Ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc; (3) N\u00e2ng cao n\u0103ng l\u1ef1c s\u1ea3n xu\u1ea5t v\u00e0 R&D v\u1edbi nh\u00e0 m\u00e1y m\u1edbi; (4) Kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng xu\u1ea5t kh\u1ea9u nh\u1edd \u0111\u00e1p \u1ee9ng ti\u00eau chu\u1ea9n EU-GMP.<\/p><\/div>

        Tuy nhi\u00ean, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u1ea7n ch\u00fa \u00fd \u0111\u1ebfn c\u00e1c r\u1ee7i ro ti\u1ec1m \u1ea9n v\u00e0 \u00e1p d\u1ee5ng c\u00e1c chi\u1ebfn l\u01b0\u1ee3c qu\u1ea3n l\u00fd r\u1ee7i ro ph\u00f9 h\u1ee3p. \u0110\u1eb7c bi\u1ec7t, c\u1ea7n theo d\u00f5i s\u00e1t sao c\u00e1c b\u00e1o c\u00e1o k\u1ebft qu\u1ea3 kinh doanh h\u00e0ng qu\u00fd, th\u00f4ng tin v\u1ec1 c\u00e1c d\u1ef1 \u00e1n \u0111\u1ea7u t\u01b0 m\u1edbi v\u00e0 ch\u00ednh s\u00e1ch ng\u00e0nh d\u01b0\u1ee3c \u0111\u1ec3 \u0111i\u1ec1u ch\u1ec9nh chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 k\u1ecbp th\u1eddi.<\/p><\/div>

        Theo d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c chuy\u00ean gia t\u1ea1i Pocket Option, v\u1edbi \u0111\u00e0 t\u0103ng tr\u01b0\u1edfng hi\u1ec7n t\u1ea1i, m\u1ee5c ti\u00eau gi\u00e1 h\u1ee3p l\u00fd cho c\u1ed5 phi\u1ebfu GPC trong 12 th\u00e1ng t\u1edbi l\u00e0 72,000-75,000 VND, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 15-20% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i. \u0110\u00e2y l\u00e0 m\u1ee9c l\u1ee3i nhu\u1eadn h\u1ea5p d\u1eabn, \u0111\u1eb7c bi\u1ec7t khi k\u1ebft h\u1ee3p v\u1edbi c\u1ed5 t\u1ee9c kho\u1ea3ng 3.5%, mang l\u1ea1i t\u1ed5ng l\u1ee3i nhu\u1eadn ti\u1ec1m n\u0103ng tr\u00ean 20% cho nh\u00e0 \u0111\u1ea7u t\u01b0.<\/p><\/div>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"

        \n

        T\u1ed5ng quan v\u1ec1 c\u1ed5 phi\u1ebfu GPC v\u00e0 v\u1ecb th\u1ebf c\u1ee7a n\u00f3 trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam<\/h2>\n<\/div>\n
        \n

        C\u1ed5 phi\u1ebfu GPC thu\u1ed9c C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm, m\u1ed9t trong nh\u1eefng doanh nghi\u1ec7p d\u01b0\u1ee3c ph\u1ea9m h\u00e0ng \u0111\u1ea7u Vi\u1ec7t Nam \u0111\u01b0\u1ee3c th\u00e0nh l\u1eadp v\u00e0o n\u0103m 1977. V\u1edbi h\u01a1n 40 n\u0103m ph\u00e1t tri\u1ec3n, Imexpharm \u0111\u00e3 x\u00e2y d\u1ef1ng \u0111\u01b0\u1ee3c v\u1ecb th\u1ebf v\u1eefng ch\u1eafc tr\u00ean th\u1ecb tr\u01b0\u1eddng d\u01b0\u1ee3c ph\u1ea9m trong n\u01b0\u1edbc v\u00e0 khu v\u1ef1c. C\u00f4ng ty chuy\u00ean s\u1ea3n xu\u1ea5t v\u00e0 kinh doanh c\u00e1c s\u1ea3n ph\u1ea9m d\u01b0\u1ee3c ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao, \u0111\u1eb7c bi\u1ec7t l\u00e0 kh\u00e1ng sinh v\u00e0 th\u1ef1c ph\u1ea9m ch\u1ee9c n\u0103ng.<\/p>\n<\/div>\n

        \n

        Trong b\u1ed1i c\u1ea3nh ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam ph\u00e1t tri\u1ec3n nhanh ch\u00f3ng, c\u1ed5 phi\u1ebfu GPC ng\u00e0y c\u00e0ng thu h\u00fat s\u1ef1 ch\u00fa \u00fd c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0. Th\u1ecb tr\u01b0\u1eddng d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111\u01b0\u1ee3c d\u1ef1 b\u00e1o s\u1ebd \u0111\u1ea1t t\u1ed1c \u0111\u1ed9 t\u0103ng tr\u01b0\u1edfng k\u00e9p h\u00e0ng n\u0103m (CAGR) kho\u1ea3ng 10-12% trong giai \u0111o\u1ea1n 2023-2028, cao h\u01a1n m\u1ee9c trung b\u00ecnh to\u00e0n c\u1ea7u. \u0110\u00e2y l\u00e0 \u0111\u1ed9ng l\u1ef1c quan tr\u1ecdng cho tri\u1ec3n v\u1ecdng ph\u00e1t tri\u1ec3n c\u1ee7a c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m trong n\u01b0\u1edbc, bao g\u1ed3m Imexpharm.<\/p>\n<\/div>\n

        \n

        V\u1ec1 v\u1ecb th\u1ebf c\u1ea1nh tranh, Imexpharm n\u1ed5i b\u1eadt v\u1edbi chi\u1ebfn l\u01b0\u1ee3c ph\u00e1t tri\u1ec3n b\u1ec1n v\u1eefng, t\u1eadp trung v\u00e0o c\u00e1c d\u00f2ng s\u1ea3n ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP v\u00e0 WHO-GMP. \u0110\u00e2y l\u00e0 l\u1ee3i th\u1ebf c\u1ea1nh tranh quan tr\u1ecdng, \u0111\u1eb7c bi\u1ec7t khi ng\u01b0\u1eddi ti\u00eau d\u00f9ng Vi\u1ec7t Nam ng\u00e0y c\u00e0ng quan t\u00e2m \u0111\u1ebfn ch\u1ea5t l\u01b0\u1ee3ng thu\u1ed1c v\u00e0 xu h\u01b0\u1edbng s\u1eed d\u1ee5ng thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc gia t\u0103ng. N\u0103m 2024, Imexpharm \u0111\u00e3 kh\u00e1nh th\u00e0nh nh\u00e0 m\u00e1y s\u1ea3n xu\u1ea5t kh\u00e1ng sinh c\u00f4ng ngh\u1ec7 cao, g\u00f3p ph\u1ea7n n\u00e2ng cao n\u0103ng l\u1ef1c s\u1ea3n xu\u1ea5t v\u00e0 m\u1edf r\u1ed9ng danh m\u1ee5c s\u1ea3n ph\u1ea9m.<\/p>\n<\/div>\n

        \n
        \n\n\n\n\n\n\n\n\n
        Ch\u1ec9 s\u1ed1<\/th>\n2022<\/th>\n2023<\/th>\n2024<\/th>\nD\u1ef1 b\u00e1o 2025<\/th>\n<\/tr>\n<\/thead>\n
        Doanh thu (t\u1ef7 VND)<\/td>\n1,480<\/td>\n1,650<\/td>\n1,842<\/td>\n2,100<\/td>\n<\/tr>\n
        L\u1ee3i nhu\u1eadn r\u00f2ng (t\u1ef7 VND)<\/td>\n248<\/td>\n290<\/td>\n325<\/td>\n380<\/td>\n<\/tr>\n
        EPS (VND)<\/td>\n3,750<\/td>\n4,200<\/td>\n4,650<\/td>\n5,400<\/td>\n<\/tr>\n
        ROE (%)<\/td>\n14.2<\/td>\n15.3<\/td>\n16.1<\/td>\n17.2<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
        \n

        Ph\u00e2n t\u00edch c\u01a1 b\u1ea3n v\u00e0 t\u00e0i ch\u00ednh c\u1ee7a c\u1ed5 phi\u1ebfu GPC<\/h2>\n<\/div>\n
        \n

        Ph\u00e2n t\u00edch c\u01a1 b\u1ea3n l\u00e0 b\u01b0\u1edbc quan tr\u1ecdng khi \u0111\u00e1nh gi\u00e1 ti\u1ec1m n\u0103ng c\u1ee7a c\u1ed5 phi\u1ebfu GPC. K\u1ebft qu\u1ea3 kinh doanh c\u1ee7a Imexpharm trong nh\u1eefng n\u0103m g\u1ea7n \u0111\u00e2y cho th\u1ea5y s\u1ef1 t\u0103ng tr\u01b0\u1edfng \u1ed5n \u0111\u1ecbnh. N\u0103m 2024, c\u00f4ng ty \u0111\u1ea1t doanh thu 1,842 t\u1ef7 VND, t\u0103ng 11.6% so v\u1edbi n\u0103m 2023. L\u1ee3i nhu\u1eadn r\u00f2ng \u0111\u1ea1t 325 t\u1ef7 VND, t\u0103ng 12.1% so v\u1edbi n\u0103m tr\u01b0\u1edbc. \u0110\u00e2y l\u00e0 m\u1ee9c t\u0103ng tr\u01b0\u1edfng \u1ea5n t\u01b0\u1ee3ng trong m\u1ed9t th\u1ecb tr\u01b0\u1eddng v\u1eabn c\u00f2n nhi\u1ec1u th\u00e1ch th\u1ee9c.<\/p>\n<\/div>\n

        \n

        C\u00e1c ch\u1ec9 s\u1ed1 t\u00e0i ch\u00ednh c\u1ee7a Imexpharm c\u0169ng kh\u00e1 t\u00edch c\u1ef1c. Bi\u00ean l\u1ee3i nhu\u1eadn g\u1ed9p \u0111\u01b0\u1ee3c duy tr\u00ec \u1edf m\u1ee9c 38-40%, cao h\u01a1n m\u1ee9c trung b\u00ecnh ng\u00e0nh. ROE (T\u1ef7 su\u1ea5t l\u1ee3i nhu\u1eadn tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu) \u0111\u1ea1t 16.1% v\u00e0o n\u0103m 2024, t\u0103ng t\u1eeb 15.3% v\u00e0o n\u0103m 2023. T\u1ef7 l\u1ec7 P\/E hi\u1ec7n t\u1ea1i kho\u1ea3ng 12-13 l\u1ea7n, th\u1ea5p h\u01a1n m\u1ee9c trung b\u00ecnh ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m kho\u1ea3ng 15-16 l\u1ea7n, cho th\u1ea5y ti\u1ec1m n\u0103ng t\u0103ng gi\u00e1 c\u1ee7a c\u1ed5 phi\u1ebfu.<\/p>\n<\/div>\n

        \n

        Ph\u00e2n t\u00edch c\u00e1c ch\u1ec9 s\u1ed1 \u0111\u1ecbnh gi\u00e1<\/h3>\n<\/div>\n
        \n
        \n\n\n\n\n\n\n\n\n
        Ch\u1ec9 s\u1ed1<\/th>\nGPC<\/th>\nTrung b\u00ecnh ng\u00e0nh<\/th>\n\u0110\u00e1nh gi\u00e1<\/th>\n<\/tr>\n<\/thead>\n
        P\/E<\/td>\n12.5<\/td>\n15.8<\/td>\nH\u1ea5p d\u1eabn<\/td>\n<\/tr>\n
        P\/B<\/td>\n1.98<\/td>\n2.25<\/td>\nH\u1ee3p l\u00fd<\/td>\n<\/tr>\n
        EV\/EBITDA<\/td>\n8.2<\/td>\n9.5<\/td>\nH\u1ea5p d\u1eabn<\/td>\n<\/tr>\n
        L\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c (%)<\/td>\n3.5<\/td>\n2.8<\/td>\nT\u1ed1t<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
        \n

        V\u1ec1 t\u00ecnh h\u00ecnh t\u00e0i ch\u00ednh, Imexpharm c\u00f3 c\u1ea5u tr\u00fac v\u1ed1n l\u00e0nh m\u1ea1nh v\u1edbi t\u1ef7 l\u1ec7 n\u1ee3 tr\u00ean v\u1ed1n ch\u1ee7 s\u1edf h\u1eefu th\u1ea5p (kho\u1ea3ng 0.3 l\u1ea7n). C\u00f4ng ty c\u00f3 l\u01b0\u1ee3ng ti\u1ec1n m\u1eb7t d\u1ed3i d\u00e0o, chi\u1ebfm kho\u1ea3ng 15% t\u1ed5ng t\u00e0i s\u1ea3n, cho ph\u00e9p doanh nghi\u1ec7p c\u00f3 \u0111\u1ee7 ngu\u1ed3n l\u1ef1c \u0111\u1ec3 t\u00e0i tr\u1ee3 cho c\u00e1c d\u1ef1 \u00e1n m\u1edf r\u1ed9ng v\u00e0 nghi\u00ean c\u1ee9u ph\u00e1t tri\u1ec3n s\u1ea3n ph\u1ea9m m\u1edbi. \u0110\u1eb7c bi\u1ec7t, trong b\u1ed1i c\u1ea3nh l\u00e3i su\u1ea5t gi\u1ea3m hi\u1ec7n nay, n\u1ee3 th\u1ea5p c\u1ee7a Imexpharm l\u00e0 m\u1ed9t l\u1ee3i th\u1ebf \u0111\u00e1ng k\u1ec3.<\/p>\n<\/div>\n

        \n

        M\u1ed9t \u0111i\u1ec3m \u0111\u00e1ng ch\u00fa \u00fd kh\u00e1c l\u00e0 ch\u00ednh s\u00e1ch c\u1ed5 t\u1ee9c c\u1ee7a c\u00f4ng ty. Imexpharm duy tr\u00ec vi\u1ec7c chi tr\u1ea3 c\u1ed5 t\u1ee9c \u0111\u1ec1u \u0111\u1eb7n kho\u1ea3ng 15-20% b\u1eb1ng ti\u1ec1n m\u1eb7t v\u00e0 c\u1ed5 phi\u1ebfu, th\u1ec3 hi\u1ec7n cam k\u1ebft chia s\u1ebb l\u1ee3i nhu\u1eadn v\u1edbi c\u1ed5 \u0111\u00f4ng. \u1ede m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i, l\u1ee3i su\u1ea5t c\u1ed5 t\u1ee9c c\u1ee7a c\u1ed5 phi\u1ebfu GPC kho\u1ea3ng 3.5%, cao h\u01a1n l\u00e3i su\u1ea5t ti\u1ec1n g\u1eedi ng\u00e2n h\u00e0ng v\u00e0 m\u1ee9c trung b\u00ecnh ng\u00e0nh.<\/p>\n<\/div>\n

        \n

        Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt v\u00e0 xu h\u01b0\u1edbng giao d\u1ecbch c\u1ee7a c\u1ed5 phi\u1ebfu GPC<\/h2>\n<\/div>\n
        \n

        Ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt cung c\u1ea5p c\u00e1i nh\u00ecn s\u00e2u s\u1eafc v\u1ec1 xu h\u01b0\u1edbng gi\u00e1 v\u00e0 \u0111i\u1ec3m v\u00e0o\/ra l\u00fd t\u01b0\u1edfng cho nh\u00e0 \u0111\u1ea7u t\u01b0. Theo bi\u1ec3u \u0111\u1ed3 k\u1ef9 thu\u1eadt, c\u1ed5 phi\u1ebfu GPC \u0111\u00e3 tr\u1ea3i qua giai \u0111o\u1ea1n t\u00edch l\u0169y trong s\u00e1u th\u00e1ng \u0111\u1ea7u n\u0103m 2024 v\u00e0 b\u1eaft \u0111\u1ea7u xu h\u01b0\u1edbng t\u0103ng t\u1eeb Q3\/2024. Hi\u1ec7n t\u1ea1i, c\u1ed5 phi\u1ebfu \u0111ang giao d\u1ecbch tr\u00ean MA50 (\u0111\u01b0\u1eddng trung b\u00ecnh \u0111\u1ed9ng 50 ng\u00e0y) v\u00e0 MA200 (\u0111\u01b0\u1eddng trung b\u00ecnh \u0111\u1ed9ng 200 ng\u00e0y), x\u00e1c nh\u1eadn xu h\u01b0\u1edbng t\u0103ng trung v\u00e0 d\u00e0i h\u1ea1n.<\/p>\n<\/div>\n

        \n

        C\u00e1c ch\u1ec9 b\u00e1o k\u1ef9 thu\u1eadt nh\u01b0 RSI (Ch\u1ec9 s\u1ed1 s\u1ee9c m\u1ea1nh t\u01b0\u01a1ng \u0111\u1ed1i) \u1edf m\u1ee9c 65, cho th\u1ea5y c\u1ed5 phi\u1ebfu ch\u01b0a v\u00e0o v\u00f9ng qu\u00e1 mua. MACD c\u0169ng n\u1eb1m tr\u00ean \u0111\u01b0\u1eddng t\u00edn hi\u1ec7u v\u1edbi \u0111\u1ed9ng l\u01b0\u1ee3ng t\u00edch c\u1ef1c. Kh\u1ed1i l\u01b0\u1ee3ng giao d\u1ecbch trung b\u00ecnh trong 20 phi\u00ean g\u1ea7n nh\u1ea5t t\u0103ng 30% so v\u1edbi 20 phi\u00ean tr\u01b0\u1edbc \u0111\u00f3, ph\u1ea3n \u00e1nh s\u1ef1 quan t\u00e2m ng\u00e0y c\u00e0ng t\u0103ng c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0.<\/p>\n<\/div>\n

        \n
        \n\n\n\n\n\n\n\n\n
        Ch\u1ec9 b\u00e1o k\u1ef9 thu\u1eadt<\/th>\nGi\u00e1 tr\u1ecb hi\u1ec7n t\u1ea1i<\/th>\nT\u00edn hi\u1ec7u<\/th>\n<\/tr>\n<\/thead>\n
        RSI (14)<\/td>\n65<\/td>\nT\u00edch c\u1ef1c<\/td>\n<\/tr>\n
        MACD (12,26,9)<\/td>\n+2.15<\/td>\nMua<\/td>\n<\/tr>\n
        Bollinger Bands<\/td>\nGiao d\u1ecbch g\u1ea7n d\u1ea3i tr\u00ean<\/td>\nT\u00edch c\u1ef1c<\/td>\n<\/tr>\n
        Stochastic<\/td>\n82<\/td>\nG\u1ea7n v\u00f9ng qu\u00e1 mua<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
        \n

        V\u1ec1 m\u1ee9c kh\u00e1ng c\u1ef1 v\u00e0 h\u1ed7 tr\u1ee3, c\u1ed5 phi\u1ebfu GPC hi\u1ec7n c\u00f3 kh\u00e1ng c\u1ef1 m\u1ea1nh \u1edf m\u1ee9c gi\u00e1 65,000 VND, t\u01b0\u01a1ng \u1ee9ng v\u1edbi \u0111\u1ec9nh cao nh\u1ea5t trong l\u1ecbch s\u1eed giao d\u1ecbch. C\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 quan tr\u1ecdng l\u00e0 58,000 VND (MA50) v\u00e0 52,000 VND (MA200). Chi\u1ebfn l\u01b0\u1ee3c giao d\u1ecbch ph\u00f9 h\u1ee3p l\u00e0 t\u00edch l\u0169y mua t\u1ea1i c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 n\u00e0y v\u00e0 c\u00e2n nh\u1eafc ch\u1ed1t l\u1eddi m\u1ed9t ph\u1ea7n khi ti\u1ebfp c\u1eadn c\u00e1c v\u00f9ng kh\u00e1ng c\u1ef1.<\/p>\n<\/div>\n

        \n

        Theo c\u00e1c nh\u00e0 ph\u00e2n t\u00edch t\u1ea1i Pocket Option, v\u1edbi \u0111\u1ed9ng l\u1ef1c hi\u1ec7n t\u1ea1i, c\u1ed5 phi\u1ebfu GPC c\u00f3 kh\u1ea3 n\u0103ng v\u01b0\u1ee3t qua m\u1ee9c kh\u00e1ng c\u1ef1 65,000 VND trong Q2\/2025, \u0111\u1eb7c bi\u1ec7t n\u1ebfu k\u1ebft qu\u1ea3 kinh doanh Q1\/2025 ti\u1ebfp t\u1ee5c kh\u1ea3 quan. Tuy nhi\u00ean, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u1ea7n ch\u00fa \u00fd \u0111\u1ebfn c\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro nh\u01b0 bi\u1ebfn \u0111\u1ed9ng chung c\u1ee7a th\u1ecb tr\u01b0\u1eddng v\u00e0 \u0111i\u1ec1u ki\u1ec7n kinh t\u1ebf v\u0129 m\u00f4 c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn xu h\u01b0\u1edbng gi\u00e1.<\/p>\n<\/div>\n

        \n

        M\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt \u0111\u00e1ng ch\u00fa \u00fd<\/h3>\n<\/div>\n
        \n

        G\u1ea7n \u0111\u00e2y, c\u1ed5 phi\u1ebfu GPC \u0111\u00e3 h\u00ecnh th\u00e0nh m\u00f4 h\u00ecnh “Cup and Handle” – m\u1ed9t m\u00f4 h\u00ecnh k\u1ef9 thu\u1eadt b\u00e1o hi\u1ec7u ti\u1ec1m n\u0103ng b\u1ee9t ph\u00e1 gi\u00e1 m\u1ea1nh. “Cup” \u0111\u01b0\u1ee3c h\u00ecnh th\u00e0nh trong 4 th\u00e1ng \u0111\u1ea7u n\u0103m 2024, ti\u1ebfp theo l\u00e0 giai \u0111o\u1ea1n “handle” k\u00e9o d\u00e0i kho\u1ea3ng 6-8 tu\u1ea7n. Theo l\u00fd thuy\u1ebft ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt, m\u1ee5c ti\u00eau gi\u00e1 sau khi ho\u00e0n th\u00e0nh m\u00f4 h\u00ecnh n\u00e0y c\u00f3 th\u1ec3 cao h\u01a1n 15-20% so v\u1edbi m\u1ee9c gi\u00e1 hi\u1ec7n t\u1ea1i.<\/p>\n<\/div>\n

        \n
          \n
        • M\u00f4 h\u00ecnh “Cup and Handle” th\u01b0\u1eddng b\u00e1o hi\u1ec7u xu h\u01b0\u1edbng t\u0103ng m\u1ea1nh<\/li>\n
        • Kh\u1ed1i l\u01b0\u1ee3ng giao d\u1ecbch t\u0103ng khi c\u1ed5 phi\u1ebfu v\u01b0\u1ee3t qua v\u00e0nh c\u1ed1c l\u00e0 t\u00edn hi\u1ec7u x\u00e1c nh\u1eadn quan tr\u1ecdng<\/li>\n
        • M\u1ee5c ti\u00eau gi\u00e1 c\u00f3 th\u1ec3 \u0111\u1ea1t 72,000-75,000 VND n\u1ebfu m\u00f4 h\u00ecnh n\u00e0y ho\u00e0n th\u00e0nh<\/li>\n<\/ul>\n<\/div>\n
          \n

          C\u00e1c y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn tri\u1ec3n v\u1ecdng c\u1ed5 phi\u1ebfu GPC<\/h2>\n<\/div>\n
          \n

          M\u00f4i tr\u01b0\u1eddng kinh t\u1ebf v\u0129 m\u00f4 \u0111\u00f3ng vai tr\u00f2 quan tr\u1ecdng trong vi\u1ec7c \u0111\u1ecbnh h\u00ecnh tri\u1ec3n v\u1ecdng c\u1ee7a c\u1ed5 phi\u1ebfu GPC. N\u0103m 2025, kinh t\u1ebf Vi\u1ec7t Nam \u0111\u01b0\u1ee3c d\u1ef1 b\u00e1o t\u0103ng tr\u01b0\u1edfng kho\u1ea3ng 6.5-7%, v\u1edbi l\u1ea1m ph\u00e1t \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t \u1edf m\u1ee9c 3.5-4%. L\u00e3i su\u1ea5t ti\u1ebfp t\u1ee5c th\u1ea5p s\u1ebd t\u1ea1o \u0111i\u1ec1u ki\u1ec7n thu\u1eadn l\u1ee3i cho doanh nghi\u1ec7p m\u1edf r\u1ed9ng \u0111\u1ea7u t\u01b0.<\/p>\n<\/div>\n

          \n

          Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111ang h\u01b0\u1edfng l\u1ee3i t\u1eeb nhi\u1ec1u xu h\u01b0\u1edbng t\u00edch c\u1ef1c. Th\u1ee9 nh\u1ea5t, d\u00e2n s\u1ed1 gi\u00e0 h\u00f3a v\u00e0 t\u1ea7ng l\u1edbp trung l\u01b0u ng\u00e0y c\u00e0ng t\u0103ng \u0111ang th\u00fac \u0111\u1ea9y nhu c\u1ea7u ch\u0103m s\u00f3c s\u1ee9c kh\u1ecfe v\u00e0 d\u01b0\u1ee3c ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao. Th\u1ee9 hai, ch\u00ednh s\u00e1ch b\u1ea3o hi\u1ec3m y t\u1ebf to\u00e0n d\u00e2n c\u1ee7a Ch\u00ednh ph\u1ee7 gi\u00fap m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng v\u00e0 t\u1ea1o nhu c\u1ea7u \u1ed5n \u0111\u1ecbnh cho thu\u1ed1c n\u1ed9i \u0111\u1ecba. Th\u1ee9 ba, xu h\u01b0\u1edbng “Make in Vietnam” v\u00e0 c\u00e1c ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc trong \u0111\u1ea5u th\u1ea7u t\u1ea1i c\u00e1c c\u01a1 s\u1edf y t\u1ebf c\u00f4ng l\u1eadp t\u1ea1o l\u1ee3i th\u1ebf cho c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m trong n\u01b0\u1edbc nh\u01b0 Imexpharm.<\/p>\n<\/div>\n

          \n
          \n\n\n\n\n\n\n\n\n\n
          Y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4<\/th>\nT\u00e1c \u0111\u1ed9ng \u0111\u1ebfn GPC<\/th>\n<\/tr>\n<\/thead>\n
          T\u0103ng tr\u01b0\u1edfng GDP 6.5-7%<\/td>\nT\u00edch c\u1ef1c<\/td>\n<\/tr>\n
          L\u1ea1m ph\u00e1t \u0111\u01b0\u1ee3c ki\u1ec3m so\u00e1t \u1edf m\u1ee9c 3.5-4%<\/td>\nT\u00edch c\u1ef1c<\/td>\n<\/tr>\n
          L\u00e3i su\u1ea5t th\u1ea5p<\/td>\nT\u00edch c\u1ef1c<\/td>\n<\/tr>\n
          Ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c n\u1ed9i \u0111\u1ecba<\/td>\nR\u1ea5t t\u00edch c\u1ef1c<\/td>\n<\/tr>\n
          D\u00e2n s\u1ed1 gi\u00e0 h\u00f3a<\/td>\nT\u00edch c\u1ef1c d\u00e0i h\u1ea1n<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
          \n

          \u0110\u00e1ng ch\u00fa \u00fd, EVFTA (Hi\u1ec7p \u0111\u1ecbnh Th\u01b0\u01a1ng m\u1ea1i T\u1ef1 do EU-Vi\u1ec7t Nam), c\u00f3 hi\u1ec7u l\u1ef1c ho\u00e0n to\u00e0n t\u1eeb n\u0103m 2024, m\u1edf ra c\u01a1 h\u1ed9i xu\u1ea5t kh\u1ea9u d\u01b0\u1ee3c ph\u1ea9m sang th\u1ecb tr\u01b0\u1eddng EU cho c\u00e1c c\u00f4ng ty \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP nh\u01b0 Imexpharm. \u0110\u00e2y l\u00e0 c\u01a1 h\u1ed9i l\u1edbn \u0111\u1ec3 c\u00f4ng ty m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng v\u00e0 t\u0103ng doanh thu xu\u1ea5t kh\u1ea9u trong nh\u1eefng n\u0103m t\u1edbi.<\/p>\n<\/div>\n

          \n

          Tuy nhi\u00ean, c\u00e1c y\u1ebfu t\u1ed1 r\u1ee7i ro c\u0169ng c\u1ea7n \u0111\u01b0\u1ee3c l\u01b0u \u00fd. C\u1ea1nh tranh t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m n\u01b0\u1edbc ngo\u00e0i v\u1edbi ti\u1ec1m l\u1ef1c t\u00e0i ch\u00ednh m\u1ea1nh v\u00e0 c\u00f4ng ngh\u1ec7 ti\u00ean ti\u1ebfn ng\u00e0y c\u00e0ng gay g\u1eaft. Chi ph\u00ed \u0111\u1ea7u v\u00e0o t\u0103ng do bi\u1ebfn \u0111\u1ed9ng t\u1ef7 gi\u00e1 v\u00e0 gi\u00e1 nguy\u00ean li\u1ec7u d\u01b0\u1ee3c ph\u1ea9m tr\u00ean th\u1ecb tr\u01b0\u1eddng th\u1ebf gi\u1edbi c\u0169ng l\u00e0 th\u00e1ch th\u1ee9c l\u1edbn. Ngo\u00e0i ra, thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch qu\u1ea3n l\u00fd d\u01b0\u1ee3c ph\u1ea9m v\u00e0 \u0111\u1ea5u th\u1ea7u thu\u1ed1c c\u00f3 th\u1ec3 \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn k\u1ebft qu\u1ea3 kinh doanh c\u1ee7a c\u00f4ng ty.<\/p>\n<\/div>\n

          \n

          Chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 ph\u00f9 h\u1ee3p cho c\u1ed5 phi\u1ebfu GPC trong n\u0103m 2025<\/h2>\n<\/div>\n
          \n

          D\u1ef1a tr\u00ean ph\u00e2n t\u00edch c\u01a1 b\u1ea3n, ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt v\u00e0 c\u00e1c y\u1ebfu t\u1ed1 kinh t\u1ebf v\u0129 m\u00f4, c\u00e1c chuy\u00ean gia t\u1ea1i Pocket Option \u0111\u1ec1 xu\u1ea5t m\u1ed9t s\u1ed1 chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 ph\u00f9 h\u1ee3p cho c\u1ed5 phi\u1ebfu GPC trong n\u0103m 2025:<\/p>\n<\/div>\n

          \n

          Ph\u00e2n b\u1ed5 danh m\u1ee5c theo th\u1eddi gian n\u1eafm gi\u1eef<\/h3>\n<\/div>\n
          \n
            \n
          • \u0110\u1ea7u t\u01b0 d\u00e0i h\u1ea1n (tr\u00ean 12 th\u00e1ng): Ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 t\u00ecm ki\u1ebfm l\u1ee3i nhu\u1eadn t\u1eeb t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng c\u1ee7a c\u00f4ng ty v\u00e0 c\u1ed5 t\u1ee9c \u0111\u1ec1u \u0111\u1eb7n. C\u00f3 th\u1ec3 ph\u00e2n b\u1ed5 5-10% danh m\u1ee5c cho GPC.<\/li>\n
          • \u0110\u1ea7u t\u01b0 trung h\u1ea1n (3-6 th\u00e1ng): T\u1eadn d\u1ee5ng xu h\u01b0\u1edbng t\u0103ng hi\u1ec7n t\u1ea1i c\u1ee7a c\u1ed5 phi\u1ebfu v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng m\u1ea1nh trong n\u0103m 2025.<\/li>\n
          • Giao d\u1ecbch ng\u1eafn h\u1ea1n: Ch\u1ec9 ph\u00f9 h\u1ee3p cho nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 kinh nghi\u1ec7m, d\u1ef1a tr\u00ean c\u00e1c t\u00edn hi\u1ec7u k\u1ef9 thu\u1eadt v\u00e0 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 ng\u1eafn h\u1ea1n.<\/li>\n<\/ul>\n<\/div>\n
            \n
            \n\n\n\n\n\n\n\n
            Lo\u1ea1i nh\u00e0 \u0111\u1ea7u t\u01b0<\/th>\nChi\u1ebfn l\u01b0\u1ee3c<\/th>\nTh\u1eddi \u0111i\u1ec3m mua<\/th>\nM\u1ee5c ti\u00eau gi\u00e1<\/th>\nC\u1eaft l\u1ed7<\/th>\n<\/tr>\n<\/thead>\n
            D\u00e0i h\u1ea1n<\/td>\nT\u00edch l\u0169y d\u1ea7n<\/td>\nGi\u00e1 quanh MA200<\/td>\n75,000-80,000<\/td>\nD\u01b0\u1edbi MA200 trong th\u1eddi gian d\u00e0i<\/td>\n<\/tr>\n
            Trung h\u1ea1n<\/td>\nMua khi b\u1ee9t ph\u00e1<\/td>\nV\u01b0\u1ee3t 65,000 v\u1edbi kh\u1ed1i l\u01b0\u1ee3ng<\/td>\n72,000-75,000<\/td>\nD\u01b0\u1edbi 58,000<\/td>\n<\/tr>\n
            Ng\u1eafn h\u1ea1n<\/td>\nGiao d\u1ecbch theo s\u00f3ng<\/td>\nKi\u1ec3m tra h\u1ed7 tr\u1ee3 th\u00e0nh c\u00f4ng<\/td>\n65,000-68,000<\/td>\nV\u01b0\u1ee3t d\u01b0\u1edbi h\u1ed7 tr\u1ee3 g\u1ea7n nh\u1ea5t<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
            \n

            \u0110\u1ed1i v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n, chi\u1ebfn l\u01b0\u1ee3c trung b\u00ecnh gi\u00e1 l\u00e0 ph\u00f9 h\u1ee3p, t\u1ee9c l\u00e0 mua c\u1ed5 phi\u1ebfu GPC \u0111\u1ec1u \u0111\u1eb7n h\u00e0ng th\u00e1ng ho\u1eb7c h\u00e0ng qu\u00fd, b\u1ea5t k\u1ec3 bi\u1ebfn \u0111\u1ed9ng gi\u00e1 ng\u1eafn h\u1ea1n. Chi\u1ebfn l\u01b0\u1ee3c n\u00e0y gi\u00fap gi\u1ea3m thi\u1ec3u r\u1ee7i ro khi th\u1ecb tr\u01b0\u1eddng bi\u1ebfn \u0111\u1ed9ng v\u00e0 t\u1ed1i \u01b0u h\u00f3a gi\u00e1 v\u1ed1n trung b\u00ecnh trong d\u00e0i h\u1ea1n.<\/p>\n<\/div>\n

            \n

            \u0110\u1ed1i v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 trung h\u1ea1n, c\u1ea7n ch\u00fa \u00fd \u0111\u1ebfn c\u01a1 h\u1ed9i khi c\u1ed5 phi\u1ebfu GPC \u0111i\u1ec1u ch\u1ec9nh v\u1ec1 c\u00e1c m\u1ee9c h\u1ed7 tr\u1ee3 quan tr\u1ecdng nh\u01b0 MA50 ho\u1eb7c MA200. \u0110\u00e2y th\u01b0\u1eddng l\u00e0 th\u1eddi \u0111i\u1ec3m thu\u1eadn l\u1ee3i \u0111\u1ec3 tham gia ho\u1eb7c t\u0103ng t\u1ef7 tr\u1ecdng. M\u1ee5c ti\u00eau gi\u00e1 trong 6-12 th\u00e1ng t\u1edbi c\u00f3 th\u1ec3 \u0111\u1ea1t 72,000-75,000 VND, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 15-20% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i.<\/p>\n<\/div>\n

            \n

            \u0110\u1ed1i v\u1edbi nh\u00e0 giao d\u1ecbch ng\u1eafn h\u1ea1n, k\u1ebft h\u1ee3p ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt v\u1edbi vi\u1ec7c theo d\u00f5i d\u00f2ng ti\u1ec1n th\u1ecb tr\u01b0\u1eddng v\u00e0 th\u00f4ng tin c\u00f4ng ty l\u00e0 chi\u1ebfn l\u01b0\u1ee3c hi\u1ec7u qu\u1ea3. C\u00e1c t\u00edn hi\u1ec7u t\u1eeb ch\u1ec9 b\u00e1o RSI, MACD v\u00e0 m\u00f4 h\u00ecnh n\u1ebfn c\u00f3 th\u1ec3 cung c\u1ea5p \u0111i\u1ec3m v\u00e0o\/ra ch\u00ednh x\u00e1c. Chi\u1ebfn l\u01b0\u1ee3c “mua t\u1ea1i h\u1ed7 tr\u1ee3, b\u00e1n t\u1ea1i kh\u00e1ng c\u1ef1” l\u00e0 ph\u00f9 h\u1ee3p trong b\u1ed1i c\u1ea3nh c\u1ed5 phi\u1ebfu \u0111ang trong xu h\u01b0\u1edbng t\u0103ng.<\/p>\n<\/div>\n

            \n

            C\u00e1c chuy\u00ean gia t\u1ea1i Pocket Option khuy\u1ebfn ngh\u1ecb nh\u00e0 \u0111\u1ea7u t\u01b0 \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c \u0111\u1ea7u t\u01b0, kh\u00f4ng t\u1eadp trung qu\u00e1 nhi\u1ec1u v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu duy nh\u1ea5t. GPC n\u00ean chi\u1ebfm t\u1ef7 tr\u1ecdng h\u1ee3p l\u00fd trong danh m\u1ee5c t\u00f9y thu\u1ed9c v\u00e0o kh\u1ea9u v\u1ecb r\u1ee7i ro v\u00e0 m\u1ee5c ti\u00eau \u0111\u1ea7u t\u01b0 c\u1ee7a m\u1ed7i ng\u01b0\u1eddi.<\/p>\n<\/div>\n

            \n

            R\u1ee7i ro v\u00e0 qu\u1ea3n l\u00fd r\u1ee7i ro khi \u0111\u1ea7u t\u01b0 v\u00e0o GPC<\/h2>\n<\/div>\n
            \n

            M\u1eb7c d\u00f9 tri\u1ec3n v\u1ecdng c\u1ee7a c\u1ed5 phi\u1ebfu GPC kh\u00e1 t\u00edch c\u1ef1c, nh\u00e0 \u0111\u1ea7u t\u01b0 v\u1eabn c\u1ea7n nh\u1eadn di\u1ec7n v\u00e0 qu\u1ea3n l\u00fd c\u00e1c r\u1ee7i ro sau:<\/p>\n<\/div>\n

            \n
              \n
            • R\u1ee7i ro ng\u00e0nh: C\u1ea1nh tranh gay g\u1eaft trong ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m, thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch qu\u1ea3n l\u00fd gi\u00e1 thu\u1ed1c<\/li>\n
            • R\u1ee7i ro kinh t\u1ebf v\u0129 m\u00f4: Bi\u1ebfn \u0111\u1ed9ng t\u1ef7 gi\u00e1, l\u1ea1m ph\u00e1t cao \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn chi ph\u00ed \u0111\u1ea7u v\u00e0o<\/li>\n
            • R\u1ee7i ro kinh doanh: K\u1ebft qu\u1ea3 kinh doanh kh\u00f4ng \u0111\u1ea1t k\u1ef3 v\u1ecdng, d\u1ef1 \u00e1n \u0111\u1ea7u t\u01b0 m\u1edbi b\u1ecb tr\u00ec ho\u00e3n<\/li>\n
            • R\u1ee7i ro th\u1ecb tr\u01b0\u1eddng: Bi\u1ebfn \u0111\u1ed9ng chung c\u1ee7a th\u1ecb tr\u01b0\u1eddng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u00e2m l\u00fd nh\u00e0 \u0111\u1ea7u t\u01b0<\/li>\n<\/ul>\n<\/div>\n
              \n

              \u0110\u1ec3 qu\u1ea3n l\u00fd r\u1ee7i ro hi\u1ec7u qu\u1ea3, nh\u00e0 \u0111\u1ea7u t\u01b0 n\u00ean \u00e1p d\u1ee5ng c\u00e1c nguy\u00ean t\u1eafc sau:<\/p>\n<\/div>\n

              \n
              \n\n\n\n\n\n\n\n\n
              Nguy\u00ean t\u1eafc<\/th>\nTh\u1ef1c hi\u1ec7n<\/th>\n<\/tr>\n<\/thead>\n
              \u0110a d\u1ea1ng h\u00f3a danh m\u1ee5c<\/td>\nKh\u00f4ng \u0111\u1ea7u t\u01b0 qu\u00e1 10% danh m\u1ee5c v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu<\/td>\n<\/tr>\n
              \u0110\u1eb7t l\u1ec7nh c\u1eaft l\u1ed7<\/td>\nC\u1eaft l\u1ed7 khi gi\u00e1 gi\u1ea3m 7-10% so v\u1edbi gi\u00e1 mua<\/td>\n<\/tr>\n
              Ph\u00e2n b\u1ed5 v\u1ed1n theo giai \u0111o\u1ea1n<\/td>\nChia nh\u1ecf l\u1ec7nh mua th\u00e0nh nhi\u1ec1u \u0111\u1ee3t<\/td>\n<\/tr>\n
              C\u1eadp nh\u1eadt th\u00f4ng tin<\/td>\nTheo d\u00f5i s\u00e1t sao k\u1ebft qu\u1ea3 kinh doanh v\u00e0 th\u00f4ng tin c\u00f4ng ty<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<\/div>\n<\/div>\n
              \n

              Ngo\u00e0i ra, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1ec3 s\u1eed d\u1ee5ng c\u00e1c c\u00f4ng c\u1ee5 qu\u1ea3n l\u00fd r\u1ee7i ro tr\u00ean n\u1ec1n t\u1ea3ng Pocket Option nh\u01b0 Stop Loss, Take Profit v\u00e0 c\u00e1c t\u00ednh n\u0103ng ph\u00e2n t\u00edch k\u1ef9 thu\u1eadt \u0111\u1ec3 theo d\u00f5i v\u00e0 \u0111i\u1ec1u ch\u1ec9nh danh m\u1ee5c \u0111\u1ea7u t\u01b0 k\u1ecbp th\u1eddi.<\/p>\n<\/div>\n

              \n

              K\u1ebft lu\u1eadn v\u1ec1 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 c\u1ed5 phi\u1ebfu GPC trong n\u0103m 2025<\/h2>\n<\/div>\n
              \n

              T\u00f3m l\u1ea1i, c\u1ed5 phi\u1ebfu GPC c\u1ee7a C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm cho th\u1ea5y ti\u1ec1m n\u0103ng \u0111\u1ea7u t\u01b0 t\u00edch c\u1ef1c trong n\u0103m 2025. V\u1edbi n\u1ec1n t\u1ea3ng c\u01a1 b\u1ea3n v\u1eefng ch\u1eafc, t\u0103ng tr\u01b0\u1edfng kinh doanh \u1ed5n \u0111\u1ecbnh v\u00e0 \u0111\u1ecbnh gi\u00e1 h\u1ee3p l\u00fd, GPC l\u00e0 l\u1ef1a ch\u1ecdn \u0111\u00e1ng c\u00e2n nh\u1eafc cho c\u1ea3 nh\u00e0 \u0111\u1ea7u t\u01b0 d\u00e0i h\u1ea1n v\u00e0 trung h\u1ea1n.<\/p>\n<\/div>\n

              \n

              C\u00e1c y\u1ebfu t\u1ed1 h\u1ed7 tr\u1ee3 t\u0103ng tr\u01b0\u1edfng bao g\u1ed3m: (1) Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111ang trong chu k\u1ef3 t\u0103ng tr\u01b0\u1edfng m\u1ea1nh; (2) Ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc; (3) N\u00e2ng cao n\u0103ng l\u1ef1c s\u1ea3n xu\u1ea5t v\u00e0 R&D v\u1edbi nh\u00e0 m\u00e1y m\u1edbi; (4) Kh\u1ea3 n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng xu\u1ea5t kh\u1ea9u nh\u1edd \u0111\u00e1p \u1ee9ng ti\u00eau chu\u1ea9n EU-GMP.<\/p>\n<\/div>\n

              \n

              Tuy nhi\u00ean, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u1ea7n ch\u00fa \u00fd \u0111\u1ebfn c\u00e1c r\u1ee7i ro ti\u1ec1m \u1ea9n v\u00e0 \u00e1p d\u1ee5ng c\u00e1c chi\u1ebfn l\u01b0\u1ee3c qu\u1ea3n l\u00fd r\u1ee7i ro ph\u00f9 h\u1ee3p. \u0110\u1eb7c bi\u1ec7t, c\u1ea7n theo d\u00f5i s\u00e1t sao c\u00e1c b\u00e1o c\u00e1o k\u1ebft qu\u1ea3 kinh doanh h\u00e0ng qu\u00fd, th\u00f4ng tin v\u1ec1 c\u00e1c d\u1ef1 \u00e1n \u0111\u1ea7u t\u01b0 m\u1edbi v\u00e0 ch\u00ednh s\u00e1ch ng\u00e0nh d\u01b0\u1ee3c \u0111\u1ec3 \u0111i\u1ec1u ch\u1ec9nh chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 k\u1ecbp th\u1eddi.<\/p>\n<\/div>\n

              \n

              Theo d\u1ef1 b\u00e1o c\u1ee7a c\u00e1c chuy\u00ean gia t\u1ea1i Pocket Option, v\u1edbi \u0111\u00e0 t\u0103ng tr\u01b0\u1edfng hi\u1ec7n t\u1ea1i, m\u1ee5c ti\u00eau gi\u00e1 h\u1ee3p l\u00fd cho c\u1ed5 phi\u1ebfu GPC trong 12 th\u00e1ng t\u1edbi l\u00e0 72,000-75,000 VND, t\u01b0\u01a1ng \u0111\u01b0\u01a1ng m\u1ee9c t\u0103ng 15-20% so v\u1edbi gi\u00e1 hi\u1ec7n t\u1ea1i. \u0110\u00e2y l\u00e0 m\u1ee9c l\u1ee3i nhu\u1eadn h\u1ea5p d\u1eabn, \u0111\u1eb7c bi\u1ec7t khi k\u1ebft h\u1ee3p v\u1edbi c\u1ed5 t\u1ee9c kho\u1ea3ng 3.5%, mang l\u1ea1i t\u1ed5ng l\u1ee3i nhu\u1eadn ti\u1ec1m n\u0103ng tr\u00ean 20% cho nh\u00e0 \u0111\u1ea7u t\u01b0.<\/p>\n<\/div>\n"},"faq":[{"question":"M\u00e3 ch\u1ee9ng kho\u00e1n GPC l\u00e0 c\u1ee7a c\u00f4ng ty n\u00e0o?","answer":"GPC l\u00e0 m\u00e3 c\u1ed5 phi\u1ebfu c\u1ee7a C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm, m\u1ed9t trong nh\u1eefng doanh nghi\u1ec7p d\u01b0\u1ee3c ph\u1ea9m h\u00e0ng \u0111\u1ea7u Vi\u1ec7t Nam \u0111\u01b0\u1ee3c th\u00e0nh l\u1eadp v\u00e0o n\u0103m 1977. C\u00f4ng ty chuy\u00ean s\u1ea3n xu\u1ea5t v\u00e0 kinh doanh c\u00e1c s\u1ea3n ph\u1ea9m d\u01b0\u1ee3c ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao, \u0111\u1eb7c bi\u1ec7t l\u00e0 kh\u00e1ng sinh v\u00e0 th\u1ef1c ph\u1ea9m ch\u1ee9c n\u0103ng \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP v\u00e0 WHO-GMP."},{"question":"L\u1ee3i th\u1ebf c\u1ea1nh tranh c\u1ee7a Imexpharm so v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m kh\u00e1c t\u1ea1i Vi\u1ec7t Nam l\u00e0 g\u00ec?","answer":"Imexpharm c\u00f3 m\u1ed9t s\u1ed1 l\u1ee3i th\u1ebf c\u1ea1nh tranh \u0111\u00e1ng ch\u00fa \u00fd: (1) \u0110\u00e2y l\u00e0 m\u1ed9t trong s\u1ed1 \u00edt c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP, cho ph\u00e9p xu\u1ea5t kh\u1ea9u sang th\u1ecb tr\u01b0\u1eddng EU; (2) C\u00f3 nh\u00e0 m\u00e1y s\u1ea3n xu\u1ea5t kh\u00e1ng sinh c\u00f4ng ngh\u1ec7 cao hi\u1ec7n \u0111\u1ea1i; (3) Kh\u1ea3 n\u0103ng R&D m\u1ea1nh m\u1ebd v\u1edbi nhi\u1ec1u s\u1ea3n ph\u1ea9m \u0111\u1ed9c quy\u1ec1n; (4) M\u1ea1ng l\u01b0\u1edbi ph\u00e2n ph\u1ed1i r\u1ed9ng kh\u1eafp to\u00e0n qu\u1ed1c; (5) T\u00ecnh h\u00ecnh t\u00e0i ch\u00ednh l\u00e0nh m\u1ea1nh v\u1edbi t\u1ef7 l\u1ec7 n\u1ee3 th\u1ea5p."},{"question":"T\u1ea1i sao c\u1ed5 phi\u1ebfu GPC \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 c\u00f3 tri\u1ec3n v\u1ecdng t\u00edch c\u1ef1c v\u00e0o n\u0103m 2025?","answer":"C\u1ed5 phi\u1ebfu GPC \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 t\u00edch c\u1ef1c v\u00ec: (1) Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111ang trong chu k\u1ef3 t\u0103ng tr\u01b0\u1edfng m\u1ea1nh v\u1edbi CAGR 10-12%; (2) Ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc t\u1ea1o l\u1ee3i th\u1ebf cho c\u00e1c doanh nghi\u1ec7p n\u1ed9i \u0111\u1ecba; (3) K\u1ebft qu\u1ea3 kinh doanh c\u1ee7a Imexpharm cho th\u1ea5y t\u0103ng tr\u01b0\u1edfng \u1ed5n \u0111\u1ecbnh; (4) \u0110\u1ecbnh gi\u00e1 h\u1ee3p l\u00fd v\u1edbi P\/E th\u1ea5p h\u01a1n trung b\u00ecnh ng\u00e0nh; (5) Ti\u1ec1m n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng xu\u1ea5t kh\u1ea9u nh\u1edd EVFTA; (6) Xu h\u01b0\u1edbng k\u1ef9 thu\u1eadt t\u00edch c\u1ef1c v\u1edbi m\u00f4 h\u00ecnh \"Cup and Handle\"."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GPC l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o GPC bao g\u1ed3m: (1) C\u1ea1nh tranh gay g\u1eaft t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m n\u01b0\u1edbc ngo\u00e0i; (2) Bi\u1ebfn \u0111\u1ed9ng gi\u00e1 nguy\u00ean li\u1ec7u d\u01b0\u1ee3c ph\u1ea9m nh\u1eadp kh\u1ea9u; (3) Thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch qu\u1ea3n l\u00fd gi\u00e1 thu\u1ed1c v\u00e0 \u0111\u1ea5u th\u1ea7u thu\u1ed1c; (4) R\u1ee7i ro t\u1ef7 gi\u00e1 h\u1ed1i \u0111o\u00e1i do ph\u1ee5 thu\u1ed9c v\u00e0o nguy\u00ean li\u1ec7u nh\u1eadp kh\u1ea9u; (5) Bi\u1ebfn \u0111\u1ed9ng chung c\u1ee7a th\u1ecb tr\u01b0\u1eddng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u00e2m l\u00fd nh\u00e0 \u0111\u1ea7u t\u01b0; (6) K\u1ebft qu\u1ea3 kinh doanh kh\u00f4ng \u0111\u1ea1t k\u1ef3 v\u1ecdng."},{"question":"Nh\u1eefng chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 n\u00e0o ph\u00f9 h\u1ee3p cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00e1 nh\u00e2n v\u1edbi c\u1ed5 phi\u1ebfu GPC?","answer":"T\u00f9y thu\u1ed9c v\u00e0o m\u1ee5c ti\u00eau v\u00e0 kh\u1ea9u v\u1ecb r\u1ee7i ro, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1ec3 \u00e1p d\u1ee5ng c\u00e1c chi\u1ebfn l\u01b0\u1ee3c sau: (1) \u0110\u1ea7u t\u01b0 d\u00e0i h\u1ea1n: T\u00edch l\u0169y d\u1ea7n khi gi\u00e1 quanh MA200, gi\u1eef trong 12+ th\u00e1ng \u0111\u1ec3 h\u01b0\u1edfng l\u1ee3i t\u1eeb t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng v\u00e0 c\u1ed5 t\u1ee9c; (2) \u0110\u1ea7u t\u01b0 trung h\u1ea1n: Mua khi c\u1ed5 phi\u1ebfu ph\u00e1 v\u1ee1 kh\u00e1ng c\u1ef1 t\u1ea1i 65,000 VND v\u1edbi kh\u1ed1i l\u01b0\u1ee3ng l\u1edbn, nh\u1eafm m\u1ee5c ti\u00eau 72,000-75,000 VND trong v\u00f2ng 6-12 th\u00e1ng; (3) Giao d\u1ecbch ng\u1eafn h\u1ea1n: \u00c1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c \"mua t\u1ea1i h\u1ed7 tr\u1ee3, b\u00e1n t\u1ea1i kh\u00e1ng c\u1ef1\" d\u1ef1a tr\u00ean t\u00edn hi\u1ec7u k\u1ef9 thu\u1eadt v\u00e0 theo d\u00f5i d\u00f2ng ti\u1ec1n. Quan tr\u1ecdng nh\u1ea5t, \u00e1p d\u1ee5ng nguy\u00ean t\u1eafc qu\u1ea3n l\u00fd r\u1ee7i ro, \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c \u0111\u1ea7u t\u01b0, v\u00e0 kh\u00f4ng \u0111\u1ea7u t\u01b0 qu\u00e1 10% danh m\u1ee5c v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu duy nh\u1ea5t."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"M\u00e3 ch\u1ee9ng kho\u00e1n GPC l\u00e0 c\u1ee7a c\u00f4ng ty n\u00e0o?","answer":"GPC l\u00e0 m\u00e3 c\u1ed5 phi\u1ebfu c\u1ee7a C\u00f4ng ty C\u1ed5 ph\u1ea7n D\u01b0\u1ee3c ph\u1ea9m Imexpharm, m\u1ed9t trong nh\u1eefng doanh nghi\u1ec7p d\u01b0\u1ee3c ph\u1ea9m h\u00e0ng \u0111\u1ea7u Vi\u1ec7t Nam \u0111\u01b0\u1ee3c th\u00e0nh l\u1eadp v\u00e0o n\u0103m 1977. C\u00f4ng ty chuy\u00ean s\u1ea3n xu\u1ea5t v\u00e0 kinh doanh c\u00e1c s\u1ea3n ph\u1ea9m d\u01b0\u1ee3c ph\u1ea9m ch\u1ea5t l\u01b0\u1ee3ng cao, \u0111\u1eb7c bi\u1ec7t l\u00e0 kh\u00e1ng sinh v\u00e0 th\u1ef1c ph\u1ea9m ch\u1ee9c n\u0103ng \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP v\u00e0 WHO-GMP."},{"question":"L\u1ee3i th\u1ebf c\u1ea1nh tranh c\u1ee7a Imexpharm so v\u1edbi c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m kh\u00e1c t\u1ea1i Vi\u1ec7t Nam l\u00e0 g\u00ec?","answer":"Imexpharm c\u00f3 m\u1ed9t s\u1ed1 l\u1ee3i th\u1ebf c\u1ea1nh tranh \u0111\u00e1ng ch\u00fa \u00fd: (1) \u0110\u00e2y l\u00e0 m\u1ed9t trong s\u1ed1 \u00edt c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111\u1ea1t ti\u00eau chu\u1ea9n EU-GMP, cho ph\u00e9p xu\u1ea5t kh\u1ea9u sang th\u1ecb tr\u01b0\u1eddng EU; (2) C\u00f3 nh\u00e0 m\u00e1y s\u1ea3n xu\u1ea5t kh\u00e1ng sinh c\u00f4ng ngh\u1ec7 cao hi\u1ec7n \u0111\u1ea1i; (3) Kh\u1ea3 n\u0103ng R&D m\u1ea1nh m\u1ebd v\u1edbi nhi\u1ec1u s\u1ea3n ph\u1ea9m \u0111\u1ed9c quy\u1ec1n; (4) M\u1ea1ng l\u01b0\u1edbi ph\u00e2n ph\u1ed1i r\u1ed9ng kh\u1eafp to\u00e0n qu\u1ed1c; (5) T\u00ecnh h\u00ecnh t\u00e0i ch\u00ednh l\u00e0nh m\u1ea1nh v\u1edbi t\u1ef7 l\u1ec7 n\u1ee3 th\u1ea5p."},{"question":"T\u1ea1i sao c\u1ed5 phi\u1ebfu GPC \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 c\u00f3 tri\u1ec3n v\u1ecdng t\u00edch c\u1ef1c v\u00e0o n\u0103m 2025?","answer":"C\u1ed5 phi\u1ebfu GPC \u0111\u01b0\u1ee3c \u0111\u00e1nh gi\u00e1 t\u00edch c\u1ef1c v\u00ec: (1) Ng\u00e0nh d\u01b0\u1ee3c ph\u1ea9m Vi\u1ec7t Nam \u0111ang trong chu k\u1ef3 t\u0103ng tr\u01b0\u1edfng m\u1ea1nh v\u1edbi CAGR 10-12%; (2) Ch\u00ednh s\u00e1ch \u01b0u ti\u00ean thu\u1ed1c s\u1ea3n xu\u1ea5t trong n\u01b0\u1edbc t\u1ea1o l\u1ee3i th\u1ebf cho c\u00e1c doanh nghi\u1ec7p n\u1ed9i \u0111\u1ecba; (3) K\u1ebft qu\u1ea3 kinh doanh c\u1ee7a Imexpharm cho th\u1ea5y t\u0103ng tr\u01b0\u1edfng \u1ed5n \u0111\u1ecbnh; (4) \u0110\u1ecbnh gi\u00e1 h\u1ee3p l\u00fd v\u1edbi P\/E th\u1ea5p h\u01a1n trung b\u00ecnh ng\u00e0nh; (5) Ti\u1ec1m n\u0103ng m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng xu\u1ea5t kh\u1ea9u nh\u1edd EVFTA; (6) Xu h\u01b0\u1edbng k\u1ef9 thu\u1eadt t\u00edch c\u1ef1c v\u1edbi m\u00f4 h\u00ecnh \"Cup and Handle\"."},{"question":"Nh\u1eefng r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu GPC l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o GPC bao g\u1ed3m: (1) C\u1ea1nh tranh gay g\u1eaft t\u1eeb c\u00e1c c\u00f4ng ty d\u01b0\u1ee3c ph\u1ea9m n\u01b0\u1edbc ngo\u00e0i; (2) Bi\u1ebfn \u0111\u1ed9ng gi\u00e1 nguy\u00ean li\u1ec7u d\u01b0\u1ee3c ph\u1ea9m nh\u1eadp kh\u1ea9u; (3) Thay \u0111\u1ed5i trong ch\u00ednh s\u00e1ch qu\u1ea3n l\u00fd gi\u00e1 thu\u1ed1c v\u00e0 \u0111\u1ea5u th\u1ea7u thu\u1ed1c; (4) R\u1ee7i ro t\u1ef7 gi\u00e1 h\u1ed1i \u0111o\u00e1i do ph\u1ee5 thu\u1ed9c v\u00e0o nguy\u00ean li\u1ec7u nh\u1eadp kh\u1ea9u; (5) Bi\u1ebfn \u0111\u1ed9ng chung c\u1ee7a th\u1ecb tr\u01b0\u1eddng \u1ea3nh h\u01b0\u1edfng \u0111\u1ebfn t\u00e2m l\u00fd nh\u00e0 \u0111\u1ea7u t\u01b0; (6) K\u1ebft qu\u1ea3 kinh doanh kh\u00f4ng \u0111\u1ea1t k\u1ef3 v\u1ecdng."},{"question":"Nh\u1eefng chi\u1ebfn l\u01b0\u1ee3c \u0111\u1ea7u t\u01b0 n\u00e0o ph\u00f9 h\u1ee3p cho c\u00e1c nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00e1 nh\u00e2n v\u1edbi c\u1ed5 phi\u1ebfu GPC?","answer":"T\u00f9y thu\u1ed9c v\u00e0o m\u1ee5c ti\u00eau v\u00e0 kh\u1ea9u v\u1ecb r\u1ee7i ro, nh\u00e0 \u0111\u1ea7u t\u01b0 c\u00f3 th\u1ec3 \u00e1p d\u1ee5ng c\u00e1c chi\u1ebfn l\u01b0\u1ee3c sau: (1) \u0110\u1ea7u t\u01b0 d\u00e0i h\u1ea1n: T\u00edch l\u0169y d\u1ea7n khi gi\u00e1 quanh MA200, gi\u1eef trong 12+ th\u00e1ng \u0111\u1ec3 h\u01b0\u1edfng l\u1ee3i t\u1eeb t\u0103ng tr\u01b0\u1edfng b\u1ec1n v\u1eefng v\u00e0 c\u1ed5 t\u1ee9c; (2) \u0110\u1ea7u t\u01b0 trung h\u1ea1n: Mua khi c\u1ed5 phi\u1ebfu ph\u00e1 v\u1ee1 kh\u00e1ng c\u1ef1 t\u1ea1i 65,000 VND v\u1edbi kh\u1ed1i l\u01b0\u1ee3ng l\u1edbn, nh\u1eafm m\u1ee5c ti\u00eau 72,000-75,000 VND trong v\u00f2ng 6-12 th\u00e1ng; (3) Giao d\u1ecbch ng\u1eafn h\u1ea1n: \u00c1p d\u1ee5ng chi\u1ebfn l\u01b0\u1ee3c \"mua t\u1ea1i h\u1ed7 tr\u1ee3, b\u00e1n t\u1ea1i kh\u00e1ng c\u1ef1\" d\u1ef1a tr\u00ean t\u00edn hi\u1ec7u k\u1ef9 thu\u1eadt v\u00e0 theo d\u00f5i d\u00f2ng ti\u1ec1n. Quan tr\u1ecdng nh\u1ea5t, \u00e1p d\u1ee5ng nguy\u00ean t\u1eafc qu\u1ea3n l\u00fd r\u1ee7i ro, \u0111a d\u1ea1ng h\u00f3a danh m\u1ee5c \u0111\u1ea7u t\u01b0, v\u00e0 kh\u00f4ng \u0111\u1ea7u t\u01b0 qu\u00e1 10% danh m\u1ee5c v\u00e0o m\u1ed9t c\u1ed5 phi\u1ebfu duy nh\u1ea5t."}]}},"yoast_head":"\nC\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-07-10T19:47:44+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\" \/>\n\t<meta property=\"og:image:width\" content=\"1840\" \/>\n\t<meta property=\"og:image:height\" content=\"700\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/webp\" \/>\n<meta name=\"author\" content=\"Andrew OK\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Andrew OK\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\"},\"author\":{\"name\":\"Andrew OK\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3\"},\"headline\":\"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025\",\"datePublished\":\"2025-07-10T19:47:44+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\"},\"wordCount\":18,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"keywords\":[\"beginner\",\"platform\",\"stock\"],\"articleSection\":[\"Markets\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\",\"name\":\"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"datePublished\":\"2025-07-10T19:47:44+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp\",\"width\":1840,\"height\":700},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3\",\"name\":\"Andrew OK\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g\",\"caption\":\"Andrew OK\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/andrew-ok\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/","og_locale":"en_US","og_type":"article","og_title":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025","og_url":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/","og_site_name":"Pocket Option blog","article_published_time":"2025-07-10T19:47:44+00:00","og_image":[{"width":1840,"height":700,"url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","type":"image\/webp"}],"author":"Andrew OK","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Andrew OK"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/"},"author":{"name":"Andrew OK","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3"},"headline":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025","datePublished":"2025-07-10T19:47:44+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/"},"wordCount":18,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","keywords":["beginner","platform","stock"],"articleSection":["Markets"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/","url":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/","name":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","datePublished":"2025-07-10T19:47:44+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/04\/1742565469779-663183839-1.webp","width":1840,"height":700},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/knowledge-base\/markets\/gpc-stock\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u1ed5 phi\u1ebfu GPC: Ph\u00e2n t\u00edch to\u00e0n di\u1ec7n v\u00e0 c\u01a1 h\u1ed9i \u0111\u1ea7u t\u01b0 2025"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/8c927d60ff98b0ebe00861e922a035d3","name":"Andrew OK","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/383d2c0dd4b219f690be51029697edeb43831adb70c4cbf4f9500ec37448a792?s=96&d=mm&r=g","caption":"Andrew OK"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/andrew-ok\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":300350,"slug":"gpc-stock","post_title":"A\u00e7\u00e3o GPC: An\u00e1lise Abrangente e Oportunidades de Investimento 2025","href":"https:\/\/pocketoption.com\/blog\/pt\/knowledge-base\/markets\/gpc-stock\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/300355","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/45"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=300355"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/300355\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/178545"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=300355"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=300355"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=300355"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}